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Abstract 
Silver nanoparticles have become common place today due to their antimicrobial properties 
however they have become particularly popular due to their potential to kill multi-resistant 
(MR) bacteria. Silver nanoparticles have shown promising results as a solution to the problem 
of antibiotic resistance. However, little is known about their spectrum of antimicrobial 
activity, their mode of action and their most effective size and morphology. Furthermore, 
there has been limited research into the effectiveness of silver nanoparticles over time, their 
leakage into the environment, their effect on natural ecosystems and their potential 
persistence in the environment. The aim of this project was to develop a silver nanoparticle 
with proven antimicrobial properties, and to gain understanding of the aging process and 
possible persistence. This was conducted by synthesising and characterising silver 
nanoparticles using different synthetic methods, determining their antimicrobial properties 
and evaluating changes in size, morphology and antimicrobial effects after aging. Particle 
morphology and size was determined via Ultraviolet–visible spectroscopy (UV-vis) and 
Scanning Electron Microscopy (SEM). Minimum Inhibitory Concentrations (MIC) and 
Minimum Bactericidal/Fungicidal Concentration (MBC/MFC) assays were performed to 
determine the extent of antimicrobial properties. The silver nanoparticle samples were then 
aged for a week under ambient conditions and again characterised by UV-vis, SEM, and MICs 
were determined. Nanoparticles synthesised by the heat reduction method produced a highly 
effective bactericidal and antifungal effect but showed stability making them potentially 
harmful to the environment. Alternatively, the chemical reduction method produced particles 
which showed antimicrobial properties against Gram-negative bacteria, were short lived and 
therefore providing a lower environmental impact. The results of this study have 
demonstrated the importance of understanding and considering the synthetic method and 
how it affects the associated silver nanoparticle aging process. 
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Chapter 1. Introduction and Objectives 
1.1. Introduction  
Due to technological advancements we can now visualise material of the nanoscale. As our 
understanding of nanomaterial has increased so has our realisation of their potential. 
Nanoparticles are defined as particles between 1-100nm in diameter. Nanoparticles can be 
made from all kinds of metals (e.g. gold (1), copper (2), platinum (3), silver (4)) and used for a 
wide range of purposes including in medical equipment and cosmetics as antimicrobials and 
for technologies such as in surface-enhanced Raman scattering and as biosensors (5-7). This 
study focuses on the synthesis of silver nanoparticles and their potential antimicrobial 
properties. Recent research has highlighted the potential persistence of silver nanoparticles 
in the environment (8). More attention needs to be drawn to synthesis methods that both 
perform well from an antimicrobial viewpoint whilst also being quick to degrade in the 
environment.  
Silver nanoparticles have become commonly used due to their ability to inhibit and kill 
microorganisms. They are used for a wide variety of products because of their antimicrobial 
behaviour. Silver nanoparticles have become particularly potential to be useful in hospitals 
due to their ability to kill MR strains of microorganisms (9). Thus, they can to be found in many 
forms of medical equipment (10).  However, there is no consensus on which form of silver 
nanoparticles are the most effective. Some literature has shown that smaller sizes of 
nanoparticle are more effective as an antimicrobial. Some studies even suggest that cubic and 
triangular shapes are more antimicrobial than spherical, however their findings were not 
conclusive. Evidence for the antimicrobial effect of silver nanoparticles, while proven to be 
true is lacking details. This is due to the multitude of different synthetic methods and the 
variety of potential nanoparticle characteristics, each with unique morphology, antimicrobial 
effects and stability(11-13). Understanding the mechanisms involved in the antimicrobial 
properties of silver is vital in the production of the most effective antimicrobial silver 
nanoparticles. 
The increased use of silver nanoparticles has resulted in silver nanoparticle detection in the 
wider environment(14). If the nanoparticles are able to retain their antimicrobial effect after 
being introduced into the natural environment, they will likely have a negative effect on 
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healthy ecosystem micro and macro organisms. Limited research has been done on the 
longevity of silver nanoparticles, and even fewer studies have examined the effect of silver 
nanoparticle surface capping on resulting stability over time. 
 
1.2. Aims and Objectives 
Previous research has shown that silver nanoparticles of different morphologies can be 
achieved through a variety of approaches. This study investigates the effect of different 
synthetic approaches on the stability and antimicrobial properties of silver nanoparticles.  
The specific objectives of this project were to: 
1. Characterise the size and shape of silver nanoparticles produced by different 
synthetic methods. 
2. Compare the antimicrobial efficacy of silver nanoparticles synthesised by different 
methods. 
3. Evaluate the effects of aging on morphology and antimicrobial properties. 
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Chapter 2. Literature Review  
In the last decade, resistant and multi-resistant microorganisms have become a major talking 
point and the cause of some fear in the scientific and medical communities. Antibiotics are 
the most common method used to treat bacterial infections. However, the careless over-use 
of antibiotics has resulted in the emergence and selection of bacterial strains which are 
genetically resistant to antibiotic treatment (15-17). Resistant and multi-resistant 
microorganisms such as bacteria or fungi are developing genetic resistance and tolerance to 
single and multiple antibiotics. A large proportion of bacteria found in hospitals today are 
resistant to at least one antibiotic(18). Antibiotic resistant bacteria have a genetic ability to 
resist the destructive effects of one or multiple antibiotics. Infections with antibiotic resistant 
bacteria can be very dangerous and difficult to treat (19, 20). Pseudomonas aeruginosa, 
Escherichia coli and Staphylococcus aureus are all examples of common infectious bacteria (21) 
. For each of these bacteria multiple antibiotic resistant strains have been identified (9, 22). 
Candida albicans is an infectious fungus which has also, in some strains, developed resistance 
to antifungal drugs (23). The emergence of antimicrobial resistant bacteria and fungi has 
pushed the need for pharmaceutical industries to rapidly develop new antibiotics. However, 
scientific breakthroughs in the development of new more effective antibiotics are finite (9, 22). 
(23) Furthermore, the ability of infectious microorganisms to develop mechanisms to 
overcome the antimicrobial properties of antibiotics makes this an important area for further 
research. This method if continued without the intervention of an alternative method will 
result in highly resistant untreatable microorganisms, able to tolerate multiple antibiotics, 
otherwise labelled as superbugs. Silver nanoparticles have been suggested as such an 
antimicrobial (24-29) . 
 
2.1 From silver to silver nanoparticles  
For centuries silver has been known to possess antimicrobial properties. Historically those 
from affluent communities would store water and food in silver jugs to keep it potable (30). 
Furthermore, the term blue bloods associated with the European monarchies is said to be 
derived from a blueish stain to their skin caused by the frequent use of silver cutlery and 
wearing of silver jewellery (31). Today a similar effect, blueish skin staining, can be seen in 
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people who frequently (daily) ingest colloidal silver due to celebrity endorsement of its 
“organic health benefits” (32). 
As society’s understanding and our ability to manipulate silver increased the utility of silver 
increased. In the 1700s silver nitrate was used to treat venereal diseases, fistulae from salivary 
glands and bone and perianal abscesses (33). In the 1800s silver wires were used as sutures to 
close up open wounds and silver nitrate solutions were used to treat conjunctivitis (31). In the 
early 19th century silver nitrate and colloidal silver became commonly used to remove 
granulated tissue, prevent bacterial infection in wounds and promote healthy wound healing 
(30). Although silver had multiple uses in medicine, a new drug penicillin emerged in the 
1940’s(30). Penicillin became widely used and increased prescription made it a commonly used 
antibiotic and antimicrobial, impacting the use of silver as an antimicrobial causing its use to 
plummet. However, due to the rise in antibiotic resistant microorganisms, silver has now re-
emerged as an alternative antimicrobial agent. 
Today silver is commonly found in hospitals where it is impregnated into dressings and 
medical devices where it aids in the prevention of bacterial infections (10). With a renewed 
focus on silver and recent advances in the science and technology of nanoparticle production, 
the creation and investigation of silver nanoparticles as a potential antimicrobial treatment is 
underway. Nanoparticles are defined as any particle with a diameter in the 1-100nm range 
(34). Silver nanoparticles have been shown to produce an increased antimicrobial effect when 
compared to silver (not of the nanoscale). This increased antimicrobial effect has been 
correlated to an increased surface area in silver nanoparticles (35). The antimicrobial 
properties of silver nanoparticles are now being utilized in a variety of different products 
including textiles, cosmetics, detergents and medical equipment (17, 36). Silver nanoparticles 
are  naturally occurring and are produced by some plants and bacteria, however at very low 
concentrations (36). Silver nanoparticles or colloidal silver has even begun to be advertised as 
a “natural’’ alternative medicine (32).  
 
2.2. Silver and silver nanoparticles as antimicrobials 
Silver is very stable when in its metallic state and provides antimicrobial properties by 
interacting with the thiol groups found in the respiratory enzymes of bacterial cells, inhibiting 
the respiration process. The effect of metallic silver on E. coli has been scientifically examined 
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to show that silver inhibited the movement of phosphates, mannitol, succinate, proline and 
glutamine (37-40). Furthermore, when metallic silver reacts with moisture it produces ionised 
silver (39). These silver ions are highly reactive and can cause extensive damage to 
microorganisms. Silver ions interact with -SH groups of membrane-bound enzymes and 
proteins, uncoupling the respiratory chain of bacteria and disrupting bacterial cell membranes 
(38, 41, 42). The antimicrobial properties of silver have, however, been improved by producing 
and using silver of the nanoscale (nanoparticles). 
Silver nanoparticles have, as presented earlier, been confirmed to have antimicrobial 
properties (Table 2.1) (24-27). Silver nanoparticles have been demonstrated to provide an 
antimicrobial effect to many microorganisms. However, the bulk of this research has been 
performed on a limited number of bacterial and fungal type (Table 2.1). Exactly how silver 
nanoparticles achieve this antimicrobial effect is not fully understood, however, many 
theories exist. The effect of silver nanoparticles has been demonstrated to be multi-facetted 
(28). The success of silver nanoparticles as an antimicrobial stems from its ability to affect many 
different aspects of microorganisms simultaneously, including the mechanisms described 
above (28). Further, the ability of silver nanoparticles to attack multiple regions makes it a great 
candidate for dealing with the problem of multi-resistant bacteria. For bacteria to become 
resistant they would have to develop multiple mechanisms simultaneously to block silver and 
such a feat of genetics is unlikely.  
Table 2.1. A summary of the literature on nanoparticle size, shape and their antimicrobial properties. MR - multi-
resistant.  
Reference size Shape 
MIC (<10% growth) 
Comments 
Microorganisms Conc. 
Kim et al. (27) 13.5nm Spherical 
Yeast (ATCC19636) >6.6nM  
 
E. coli 
(ATCC43890) 
>3.3nM  
S. aureus (Bovine 
mastitis) 
>33nM  
Das et al. (9) 16 ±2nm 
Truncated 
triangles 
MR E. coli 4ug/ml Cell membrane 
damage followed by 
ROS generation MR S. aureus 8ug/ml 
Radzig et al. 
(24) 
8.3 
±1.9nm 
Spherical 
E. coli (AB1157) 
0.5+/-
0.25ug/ml Suggest silver ions are 
not the only mode of 
action of silver 
nanoparticles. 
Silver nitrate reported 
to be more effective. 
P. aeruginosa 
(PAO1) 
8+/-0.3ug/ml 
P. chlororaphis 
(449) 
8+/-0.2ug/ml 
S. proteamaculans 
(94) 
2+/-
0.25ug/ml 
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Sondi et al. (26) 
12nm 
Spherical 
E. coli 20ug/ml 
 21 
±18nm 
E. coli, 
P. aeruginosa, 
V. cholerae and 
S. typhus 
No significant 
growth at 
75ug/ml 
Bondarenko et 
al. (43) 
Casein 5-
30nm 
 
Spherical 
E. coli (MC1061) 20µg/ml 
Highlighted the 
importance of cell to 
silver nanoparticles 
interactions in particle 
toxicity. 
P. aeruginosa 
(DS10-129) 
3.5µg/ml 
PVP 8-
11nm 
E. coli (MC1061) 10µg/ml 
P. aeruginosa 
(DS10-129) 
7µg/ml 
Kubo et al. (44) 
14.5 
±5.2nm 
Spherical 
E. coli (MC1061) 0.5µg/ml Found the 
antimicrobial effect as 
driven by silver ions 
release. 
S. aureus (6538) 2µg/ml 
Hwang et al. 
(45) 
3nm Spherical 
E. coli 
(ATCC25922) 
2µg/ml 
The antimicrobial 
effect is influenced by 
ATP-associated 
metabolism 
P. aeruginosa 
(ATCC27853) 
0.5µg/ml 
Kora et al. (46) 5nm Spherical E. coli (25922) 2.0µg/ml  
Mohan et al. 
(47) 
19.41nm Spherical 
E. coli ATCC 1.7µg/ml 
 
P. aeruginosa (PA 
27853) 
21.4µg/ml 
Agnihotri et al. 
(48) 
5-100nm Spherical 
E. coli MTCC443 20-110 µg/ml Bactericidal properties 
to be size and dose-
dependent. 
S. aureus NCIM 
5021 
70-200 µg/ml 
Panáček et al. 
(13) 
25nm Spherical 
C. albicans I 0.1µg/ml 
 
C. albicans II 0.21µg/ml 
Martinez-
Castanon et al. 
(49) 
89nm Spherical 
E. coli 
(ATCC25922) 
11.79µg/ml Antimicrobial activity 
varies with silver 
nanoparticles size 
S. aureus 
(ATCC25923) 
33.71µg/ml 
Kalishwaralal 
et al. (36) 
50 ±5nm Spherical P. aeruginosa 9.5 ±0.9mm  
Longhi et al. 
(23) 
NA NA 
C. albicans 
ATCC26790 
4.35µg/ml  
Yakout et al. 
(50) 
NA NA 
S. aureus 
12.2 
±0.11mm  
P. aeruginosa 12.3 ±0.2mm 
Radzig et al. 
(24) 
8.3 
±1.9nm 
Spherical 
E. coli AB1157 
0.5 
±0.25µg/ml 
Oxidamages in DNA 
can effect 
antibacterial effects 
P. aeruginosa 
PAO1 
8.0 ±0.3µg/ml 
 
Silver nanoparticles have an antimicrobial effect both directly and via the release of reactive 
silver ions (25, 29, 36). Silver nanoparticles/silver ions have in many cases been shown to damage 
bacterial cell walls and membranes. There are lots of contrasting and conflicting views on the 
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mechanisms of silver nanoparticles antimicrobial effects. Further, distinguishing the 
mechanism of antimicrobial effect between the different silver nanoparticles types is 
challenging. Pal et al. (51) demonstrated that silver ions damage bacterial cell walls, causing 
pits and breaks to form, resulting in cell lysis and allowing silver nanoparticles to penetrate 
the cell. The pits and breaks in the cell wall were seen using transmission electron microscopy 
with silver nanoparticles identified within the cell. Alternatively, Agnihotri et al. (52) and 
Bondarenko et al. (43) found that direct contact of the nanoparticle with the bacterial cell wall 
played a crucial role, and that reactive oxygen species, produced by cells to silver nanoparticle 
interactions provided a more potent antibacterial effect.  Hwang et al. (53) found that cells 
exposed to silver nanoparticles strongly induced the SodA promoter which is a stress specific 
gene, suggesting the production of superoxide radicals, ultimately showing an effect via 
membrane and oxidative stress damage. Bondarenko et al. (43) found that the silver 
nanoparticle interaction with cells resulted in an increased release of silver ions, from the 
silver nanoparticles, giving a more potent antimicrobial effect. Further, this silver nanoparticle 
to cell interaction allowed for the targeted release of a high concentration of silver ions (54). 
The targeted release is even more devastating once the nanoparticles have penetrated the 
cell. Once the silver nanoparticles were inside the cell, damage to cellular DNA was identified 
(25). Silver has a greater tendency to react with sulfur and phosphorus (28). Thus sulfur-
containing proteins in the membrane or phosphorous-containing elements such as DNA were 
specific target sites for silver nanoparticles.  
Not all microorganisms are the same. Fungal and bacterial cells are vastly different in 
structure. Within bacteria there are also vast differences in cell structure. There are two types 
of bacteria, Gram-negative and Gram-positive bacteria, with the Gram-negative bacteria 
possessing an outer membrane covering the peptidoglycan cell wall (55). Thus, Gram-negative 
bacterial cells are often, particularly in the case of P. aeruginosa harder to treat or destroy. 
This, however, has not been found to be consistently true in the case of silver nanoparticles 
(Table 2.1). In a number of cases, Gram-negative bacteria have been shown to be more 
susceptible to silver nanoparticles than Gram-positive bacteria (27, 44, 48). Studies of silver 
nanoparticles have reported that porins in the outer cell membrane of Gram-negative 
bacteria are a suggested site of silver ion/silver nanoparticle interaction and uptake, resulting 
in the stronger effectiveness of silver nanoparticles against Gram-negative bacteria (24).  
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Morones et al. (25) and Hachicho et al. (56) further demonstrated the destructive effect silver 
nanoparticles have on bacterial DNA and their membrane proteins. Sondi et al. (26) found that 
DNA loses its replicability when exposed to silver nanoparticles whereas cellular proteins 
become inactivated possibly by silver ions. Morones et al. (25) found that for Gram-negative 
bacteria, nanoparticles in the 1-10nm range can attach to the surface of the cell membrane 
disrupting normal functions such as permeability and respiration. Additionally, they are able 
to penetrate inside the bacteria and cause damage by interacting with sulfur and phosphorus 
compounds such as DNA(25). The release of silver ions also has an additional contribution to 
the antimicrobial effect(25). Silver’s ability to produce such a multifaceted antimicrobial effect 
on microorganisms is the reason for its success, and for the boom in its wide spread use. 
 
2.2.1. Which properties of silver nanoparticles affect their ability to damage 
microbes? 
Silver nanoparticles can be made into a wide variety of morphologies(57). The effect of size on 
the antimicrobial properties of spherical silver nanoparticles has been the most studied(48, 58) 
and it has been reported that the smaller the particle size the greater the antimicrobial effect 
(34, 59). This increased antimicrobial effect has been linked to an increased surface area of 
smaller nanoparticles. Tao et al. (60) found in his study that spherical silver nanoparticles that 
were 10nm were more effective that those at 100nm. This suggests that smaller silver 
nanoparticles have an increased antimicrobial effect compared to their larger counterpart. 
The varied antimicrobial effect of different particle shapes is less understood. Studies show 
that nanoparticles made up of unstable surface facets are more reactive (51, 60-62). Similarly, a 
study by Pal et al. (51) showed an increase in antimicrobial activity in {111} facet bound prisms, 
when compared to spherical nanoparticles. Sadeghi et al. (62) found that the silver 
nanoparticles with plate and rod shapes were more effective than spherical particles likely 
due to the higher percentage of {111} surface facets found in plates and rods. Research 
conducted on the reactivity of silver has demonstrated that the reactivity is favoured by high 
atom density facets such as {111} (63). It is hypothesised that the increased instability caused 
by the facet binding, may increase antimicrobial activity (51). The unstable nanoparticles are 
thought to have an increased release rate of silver ions resulting in an increase in 
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effectiveness. Therefore, it is likely that silver nanoparticles shape impacts its antimicrobial 
effect.  
The choice of stabilising or capping agents used to synthesise silver nanoparticles is also 
suggested to play an important role in the effectiveness of silver nanoparticles as an 
antimicrobial. The choice of capping agent directly affects the surface coating of the silver 
nanoparticles and their ion release kinetics(64). Damm et al. (65) found that the release of silver 
ions from the silver nanoparticles varied with different polymers. However, there is little 
known about the effect of capping agents on the antimicrobial properties of silver 
nanoparticles. Despite this limited knowledge, it has become clear that the capping agent 
used in silver nanoparticle synthesis is capable of impacting the antimicrobial effect presented 
by the silver nanoparticles. 
When synthesising the most effective silver nanoparticles it is important to take into 
consideration the size, shape and capping agent. By optimising these characteristics, the 
antimicrobial potential of silver nanoparticles can be better realised.   
 
2.3. Synthesis of silver nanoparticles 
Silver nanoparticles are naturally occurring phenomena. Silver nanoparticles are naturally 
synthesised by some specific plants, fungi, bacteria and yeasts at very low levels  (66-70). In the 
laboratory however, silver nanoparticles can be synthesised by chemical reduction, heat 
reduction, electrochemical reduction, photochemical reduction, γ-ray irradiation, UV-
irradiation and ultrasonically (71-79) (Table 2.2). The chemical and heat reduction methods are 
the most commonly used synthesis pathways. This is due to the relative ease in set up, the 
need for less equipment, as well as the high production of silver nanoparticles. Silver 
nanoparticle formation follows a reasonably well-established pattern of coalescence(80, 81). 
First the silver nanoparticles are reduced in the reduction stage, this is then followed by a 
growth stage.  
The first step in the reduction stage is a rapid reduction of silver, usually in the form of a silver 
salt, to elemental silver, which can be observed in the first 400ms(81). The silver is first reduced 
to silver ions which then form silver atoms, also known as silver precursors. The silver 
precursors then nucleate to form Ag₁₃ clusters roughly 0.7nm in diameter (82). After 1-3 
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seconds, the Ag₁₃  clusters begin to further coalesce to form silver seeds 2-3nm in 
size(83)(Figure 2.1). As the Ag₁₃ clusters amalgamate, particle number decreases and mean 
particle diameter increases(81). Coalescence of Ag₁₃ clusters continues until the majority of 
free clusters are depleted. This can take between two and ten minutes depending on the 
reaction condition i.e. capping/reducing agent. The result of the reduction stage is the 
production of single particle seeds. These particle seeds are able, with chemical tuning in the 
growth stage, to become a variety of different sizes and shapes(57). The particles then enter 
the growth stage. 
During the growth stage differences in shape and size of nanoparticles are observable and of 
great interest to this project. As coalescence continues the capping agent is able to bind and 
can limit the growth of specific surface facets, resulting in shape selectivity(57, 60). 
Manipulation of the capping agent and protocol will influence the particle growth, 
coalescence and aggregation.  
 
 
Figure 2.1. Formation mechanisms of silver nanoparticles and their associated stage adapted from Takesue et 
al. (82). 
 
Particle characteristics such as coalescence and size can be explored by standard Ultraviolet-
Visible spectroscopy (UV-vis) approaches during standard synthesis protocols.  To investigate 
and confirm particle shape however, powerful microscopy systems such as Transmission 
Electron microscopy (TEM) must be utilized. TEM will allow for reliable confirmation on 
particle shape, shape uniformity and size distributions. The ability to control particle 
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morphology with a high level of accuracy should allow for the development of silver 
nanoparticles with improved antimicrobial properties.  
 
Table 2.2. A summary of literature in silver nanoparticle on capping agents, reduction methods, size and shape. 
*indicates Mw x1000. 
Reference  
Reduction 
method 
Capping agent Size Shape 
Notes on 
synthesis 
Sun et al. (84) Heat, 160°C PVP 
115 ±7nm 
and 95 
±7nm 
Nanocubes Polyol process 
Kim et al. (27) 
Chemical, 
Sodium 
borohydride 
No capping agent 13.5nm Spherical 
Reaction was 
performed on ice 
with constant 
siring for 1 hr. 
Solomon et al. 
(85) 
Chemical, 
Sodium 
borohydride 
No capping agent 12nm Spherical  
Ivask et al. (59) 
Chemical, 
Sodium 
borohydride 
PVP (40)* 17.9 ±7nm Spherical  
Agnihotri et al. 
(48) 
Chemical, 
Sodium 
borohydride 
Sodium citrate 8.4 ±0.6nm Spherical 
A deep red wine 
colour indicated 
silver 
nanoparticle 
synthesis. 
Pal et al. (51) 
Heat, ~100°C 
Sodium citrate 
39nm Spherical Greenish yellow 
Chemical, 
Ascorbic acid, 
cetyltrimethyl-
ammonium 
bromide and 
sodium 
hydroxide 
192 x 16nm Rod Red 
Das et al. (9) 
Chemical, 
Biomass (O. 
gratissiumum 
leaf) 
O. gratissiumum 
leaf 
16 ±2nm 
Truncated 
triangles 
Bio reduction 
method 
Sondi et al. (26) 
Chemical, 
Ascorbic acid 
Daxad 19 12nm Spherical 
Synthesis under 
continuous 
stirring at room 
temp. 
Sample was 
freeze dried and 
rehydrated upon 
use. 
Xu et al. (61) Heat, 140°C PVP (30)* 
50 ±10nm  Spherical 
In solution of 
DMF 
50 ±5nm Nanocubes 
15 ±5nm 
Truncated 
triangles 
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Wiley et al. (86) Heat, 160°C PVP 
75nm Bipyramids 
HCl added formed 
sharp nanocubes 
after 26hrs 
20 x 150nm Nanorods 
90nm Spherical 
75nm Nanocubes 
Skrabalak et 
al. (87) 
Heat, 150°C PVP 
45nm & 
90nm 
Nanocubes  
Mulfinger et 
al. (88) 
Chemical, 
sodium 
borohydride 
PVP (10)* 10-14nm NA  
Ruditskiy et al. 
(11) 
Heat, 142°C PVP 13.4 ±0.4nm Nanocubes  
Jin et al. (12) 
Chemical, 
sodium 
borohydride 
Trisodium citrate 15.6 ±1.4nm Triangles  
Sun et al. (89) Heat, 160°C PVP 
30-60nm x 
1-50um 
Nanorods Polyol process 
Rao et al. (72) 
Gamma 
radiolysis 
Gum acacia 2.9 & 3.6nm Spherical Gamma radiolysis 
Chen et al. (90) Heat, 140°C Oleylamine 9.8 ±4.7nm Spherical Paraffin solvent 
Tao et al. (60) Heat  Not given 148nm Octahedral  
Kubo et al. (44) Chemical, 
sodium 
borohydride 
PVP (40)* 14.5 ±5.2nm 
Spherical  
 Poly-L-lysine 13.5 ±7.1nm 
Hwang et al. 
(45) 
Chemical, 
Sodium 
chloride 
None 3nm Spherical  
Kora et al. (46) Heat, 121°C Gum kondagogu 4.5 ±3.1nm Spherical  
Mohan et al. 
(47) 
Chemical Starch 
19.41 
±3.44nm 
Spherical 
Completely green 
synthesis method 
Zhang et al. (91) Heat, 150°C PVP (55)* 154 ±5nm Nanocubes HCl was also used 
Han et al. (92) Heat, 140°C PVP (55)* ~200nm Nanocubes 
Reaction was 
performed for 4 
hours, HCl was 
added 
Ivask et al. (93) 
Chemical, 
Sodium 
borohydride 
PVP (40)* 17.9 ±7nm Spherical  
 UV irradiation 
Branched 
polyethyleneimine 
(BPEI) 
23.3 ±15nm Spherical  
Agnihotri et al. 
(48) 
Chemical, 
sodium 
borohydride 
Trisodium citrate 5-100nm Spherical 
Mixed then 
heated 60C for 
30min 
Sun et al. (94) Heat, 160°C PVP (55)* 111 ±13nm Nanocubic  
Panáček et al. 
(13) 
Chemical, 
Sodium 
hydroxide and 
ammonia 
PVP 25nm Spherical  
Agnihotri et al. 
(52) 
Chemical, 
Sodium 
borohydride 
Trisodium citrate 8.4 ±1.2nm Spherical  
Darcy Burns-Dunn, 18018282                                                                                               
13 
 
 
 
2.4. Stages in synthesis of silver nanoparticles  
Production of metal monodispersed particles at the nanoscale can be difficult to achieve and 
control. Despite considerable research into the synthesis of nanoparticles, the replication of 
published methods is haphazard. Regulating particle size and shape in synthesis is particularly 
challenging, and there has been limited success in controlling nanoparticle shape and 
maintaining particle uniformity. For the shape of particles at the nanoscale to be controlled, 
particles need to be prevented from nucleating to form twinned particles (61, 84). This can be 
achieved by controlling surface facet binding. In the case of silver nanoparticles there has 
been considerable success in producing spherical nanoparticles (25-27, 45). However, there has 
been very little success in the uniform synthesis of cubic, rod or octahedral nanoparticles (6) 
(Table 2.2). Standard production of silver nanoparticles requires the reduction of a silver salt 
to elemental silver and the use of a capping agent to maintain the dispersed nanoparticles 
and control particle growth (99). Silver nanoparticle characteristics can be altered by selecting 
Pastoriza-
Santos et al. 
(95) 
Heat, 156°C PVP (10)* 3-30nm Spherical 
Reaction 
performed under 
reflux in N,N-
dimethylflorm-
amide 
Tsuji et al. (96) Heat, 198°C 
PVP (10)* 160nm 
Rod 
shaped 
Addition of 
Chloroplatinic 
Acid Hexahydrate 
PVP (40)* 0.5-4µm 
PVP (360)* 1-20µm 
Martinez-
Castanon et al. 
(49) 
UV-light none 89nm Spherical  
Kalishwaralal 
et al. (36) 
Bacterial B. licheniformis 50 ±5nm Spherical 
Synthesised 
biologically using 
bacteria 
Polte et al. (81) Chemical,  
sodium 
borohydride 
none 5-15nm 
Spherical  
 PVP (58)* 5-7nm 
Longhi et al. 
(23) 
Biomass, 
Fusarium 
Oxysporum 
(551) 
F. Oxysporum 
(551) 
N/a N/a Biosynthesised 
Pongkitdachoti 
et al. (97) 
Chemical,  
Sodium 
borohydride 
starch 8-20nm Spherical 
Temperature was 
increase to 100°C 
for 2 hours post 
synthesis 
Bollella et al. 
(98) 
Chemical, 
quercetin 
none 8nm Spherical Solubilised in PBS 
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a reduction technique in the reduction stage and selecting a capping agent used through the 
growth stage.  
 
2.4.1. Reduction stage 
The first stage of nanoparticle synthesis is the reduction stage. The silver salt can be reduced 
using several different methods such as a chemical reducing agent, heat, sonication, 
ultraviolet rays and even laser irradiation (Section 2.4). The most common approaches used 
are chemical or heat reduction.  
The choice of reducing agent impacts the final product synthesised. For the chemical 
reduction method, the reduction and subsequent agglomeration is rapid and often results in 
a less uniform silver product, often only allowing for the production of spherical nanoparticles  
(57). This rapid agglomeration is driven by the elemental silver’s instability and a need to 
become stable. The spherical shape is the most stable nanoparticle form, due to its low 
surface energy and thermodynamic stability, therefore silver nanoparticles made using a 
chemical reduction method often result in the formation of spherical nanoparticles (99, 100). 
Examples of chemical reducing agents include sodium hypophosphite, sodium hydroxide, 
sodium chloride, ascorbic acid and quercetin, however sodium borohydride is the most 
commonly used (Table 2.2) (13, 26, 45, 51, 98).  Chemical reduction synthesis is a simple and rapid 
method for the synthesis of spherical nanoparticles. 
To produce non-spherical particles, a heat reduction method or ‘polyol method’ of synthesis 
needs to be adopted.  In this approach, ethylene glycol (EG) is used as a solvent and high 
temperatures are used as the reducing agent (61, 84, 94, 101). Additionally, sodium sulfide is added 
as a catalyst for the reduction of silver nitrate (87). The addition of the catalyst promotes the 
production of uniform nanoparticles by increasing the speed of the reaction, limiting 
nucleation and reducing the formation of twinned particles(87). The production of non-
spherical shapes also requires elevated temperature (130-180°C) (60, 84). Heat increases the 
energy in the reaction and allows the formation of unstable facets and complex shapes such 
as cubes, rods, octahedron and tetrahedrons. When the synthesis temperature falls between 
the 160-180°C range this reduction method has been shown to produce large percentages of 
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rod-shaped particles. Furthermore, silver nanoparticles produced via this method tend to be 
smaller in size <10nm.  
There are many other reduction methods such as UV-irradiation and Gamma radiolysis which 
have shown reasonable success, however the chemical and heat reduction methods are the 
most common (Table 2.2) (49, 72, 93). The choice of reduction method has an important effect 
on the product of silver nanoparticle synthesis. 
 
2.4.2. Growth stage  
The next stage is the growth stage. This stage is important as the majority of the silver 
nanoparticle characteristics can be controlled in this stage. These controls are predominantly 
provided by the choice of capping agent. As the silver Ag₁₃ clusters begin to agglomerate and 
form small particles, a capping agent can be added for stabilization and to promote shape 
growth(102). Further, the capping agent prevents particle aggregation and maintains the silver 
nanoparticles monodispersed in solution. There are many available options for capping 
agents, some examples include; starch, polyvinylpyrrolidone (PVP) and citrate (Figure 2.2) 
(102). The approach used to produce the silver nanoparticles is chosen based on the desired 
particle morphology. 
 
 
Figure 2.2. Capping agent structures of starch, PVP and citrate. 
 
2.4.2.1. Starch  
Recent concerns about the toxic environmental effect of silver nanoparticles have prompted 
the investigation into greener synthesis methods. Biopolymers such as starch and other 
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polymers extracted from biomass can and have been used as a capping agent (Table 2.2) (46, 
103, 104). Further, some biopolymers have even been shown to reduce silver as well as cap it. 
Starch is a linear polymer, formed by the α-(1→4) linkages between D-glucose units and 
adopts a left-hand helical confirmation in an aqueous solution(105) (Figure 2.2). When the silver 
nitrate is reduced to Ag⁺ in the presence of starch, the extensive network of hydrogen bonds, 
within the starch structure, provides surface passivation and protection against nanoparticle 
aggregation (106).  
Unlike other capping agents starch showed no specificity to any specific surface facet. The use 
of starch as the capping agent has only been reported to produce spherical nanoparticles, 
however size variations have been reported (Table 2.2). Spherical nanoparticles are the most 
readily produced shape because of their increased stability and low total surface energy(99). 
Spherical particles may be the easiest particle shape to make, however studies suggest that 
other more complex particle shapes have been more effective against bacteria, as a result of 
their instability (25, 34).  
 
2.4.2.2. PVP 
The most widely used substance for capping and stabilising metal nanoparticles are ligands 
and polymers (Table 2.2). Particularly polymers with an affinity towards metals and are 
soluble in suitable solvents (Figure 2.2). PVP is an example of such a polymer and has the 
added benefit of also being a nontoxic capping agent. These polymers are able to control the 
reduction rate of the metal ions and the aggregation process of zero valent metal atoms. 
Different capping agents preferentially bind to particular surface facets and can be utilised to 
manipulate the ultimate shape of the nanoparticle(101). However, preferential binding has only 
been observed when the synthesis temperature is elevated, particularly in the heat reduction 
method. Polyvinyl pyrrolidine (PVP) selectively binds to {100} facets, resulting in formation of 
nanocubes (Figure 2.3). By selecting for {100} facets the particles grow until they are only 
covered by {100} facets, resulting in cubic morphologies. It has also been shown that elevated 
temperatures above 160°C produce nanorods/wires. This is due to the high energy in the 
synthesis allowing the formation of twin-seeded nanoparticles which grow outwards into rod-
like shapes (Figure 2.3). 
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Figure 2.3. The formation mechanisms of differently shapes silver nanoparticles based on the literature. 
 
2.4.2.3. Citrate  
The use of citrate as a capping agent has been a popular choice for many silver nanoparticle 
synthesis (107, 108). Unfortunately, however the citrate capped silver nanoparticle suspension 
has been found to produce wider size and shape variations (109). Citrate preferentially binds 
to the {111} facets (triangular flat surfaces) resulting in octahedron shaped nanoparticles 
(Figure 2.3)  (6, 99). However, like the PVP synthesise an elevated temperature is needed for 
this preferential binding to occur. 
Silver nanoparticles can be synthesised using a wide variety of methods and a large range of 
capping agents. There are many other capping agents available each with slightly different 
capping abilities and specificities. Examples include; various plant biomass’s, Daxad 19, 
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Oleylamine, Poly-L-lysine and Branched polyethyleneimine (BPEI) (Table 2.2)(9, 26, 44, 90, 93). 
However, the ones outlined in Section 2.4.1. are the most commonly used. When synthesising 
silver nanoparticles, it is important to take into consideration which is the most appropriate 
method to produce your desired final product. 
 
2.4.3.  Characterising nanoparticles 
To investigate and confirm particle shape, powerful microscopy systems such as Scanning 
Electron microscopy (SEM) must be utilized. SEM allows for reliable confirmation on particle 
shape, shape uniformity and size distributions. The ability to control particle morphology with 
a high level of accuracy allows for the development of silver nanoparticles with improved 
antimicrobial properties. The cubic, rod and octahedral particles are considered more 
unstable than the spherical particles(57). It is hypothesised that this instability, rather than 
being detrimental, may result in an increased antimicrobial effect(25). Unlike spherical 
particles the effects of cubic and octahedral silver nanoparticles on bacteria are not well 
known. 
 
2.5. The effect of silver nanoparticles over time 
The antimicrobial properties of silver nanoparticles are partially linked to the release of silver 
ions(26). This ion release cannot be indefinitely maintained and overtime silver nanoparticles 
lose their reactivity and eventually become inert (110, 111). Unstable particle shapes are 
predicted to become inert quicker than their stable spherical shape counterpart.  
The effects of silver nanoparticles on the environment are not well established. Silver 
nanoparticles have already become commonplace in many products, as highlighted earlier. 
The silver nanoparticles from these products enter waterways and soils and can cause harmful 
effects to aquatic and soil ecosystems(7, 34, 112). Recent questions have been raised about how 
long these silver nanoparticles are active and whether they can cause toxicity in the 
environment. Studies have demonstrated that low concentrations of silver nanoparticles can 
have harmful effects on environmental (non-infectious) strains of bacteria, fish embryos and 
plant shoots(34, 113). These studies were however conducted using fresh silver nanoparticles.  
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A true test would be to experiment with slightly aged nanoparticles that have been exposed 
to varied conditions (e.g. pH changes). It is hypothesised that such a test would find silver 
nanoparticles to be somewhat less toxic, owing to the progression of nanoparticles from 
reactive to inert, and a slowing in the release of silver ions. However, silver nanoparticles have 
been found to cause damaging effects to non-target organisms and natural ecosystems. 
A study by  Coutris et al. (114) found that spherical silver nanoparticles in soil showed 
continuous production of bioaccessible silver ions over a 10-week span. Alternately, Le Ouay 
et al. (54) found that silver nanoparticles could only act as silver ion reservoirs for several days. 
There are many conflicting views on the fate of silver nanoparticles in the environment. There 
are also some conflicting views on the effect of naturally occurring organic matter, ubiquitous 
to natural environments, on silver nanoparticles. Afshinnia et al. (115) and Louie et al. (116) found 
natural organic matter destabilises silver nanoparticles. While Gunsolus et al. (117) and Li et al. 
(118) found no noticeable effect on the particle stability. These examples of contrasting results 
could be due to differences in the silver nanoparticles characteristics and the synthesis 
methods chosen, particularly the capping agent used. The lifespan and fate of silver 
nanoparticles is therefore not confidently known. A greater understanding of the ageing 
process is important, not only for producing highly effective antimicrobials, but also for 
determining their effect and persistence in the environment.  
Silver nanoparticle characteristics such as shape, size and capping agent have been found to 
influence how impactful silver nanoparticles are on the environment. The nanoparticle 
instability which has been found to provide the non-spherical particles with their increased 
bactericidal effect may also, due to the instability, degrade and become inert more quickly(51). 
If the unstable faceted nanoparticles have an increased release rate of silver ions it is possible 
to hypothesise a reduced nanoparticle lifespan. Not only does shape effect the aging speed 
but it also effects how they interact with the environment. Gorka et al. (119) found that cubic 
nanoparticles were less toxic to grass roots and shoots than spherical particles. The effects of 
silver nanoparticles on the environment is dependent upon their physicochemical properties. 
Many reports have demonstrated a correlation between toxicity of silver nanoparticles and 
their size, shape and surface properties(120). If we understand the role of silver nanoparticle 
morphology, on their environmental impact, we can begin to produce silver nanoparticles 
with less harmful morphologies. A better understanding of silver nanoparticles environmental 
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impact can be attained by identifying the rate at which differently shaped silver nanoparticles 
age. This understanding will aid in the development of effective, yet environmentally friendly, 
silver nanoparticles.  
 
There has been limited research into the effectiveness of silver nanoparticles over time, 
particularly their leakage into the environment, their effect on natural ecosystems and their 
potential persistence in the environment. The aim of this project was to develop a silver 
nanoparticle with a proven antimicrobial capacity, a low environmental impact and to better 
understand the underlying mechanism involved.  
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Chapter 3. Materials and methods  
In this study silver nanoparticles were synthesised using either a chemical reduction method 
or a heat reduction method. The silver nanoparticles produced were then physically 
characterised using UV-vis and SEM and then also tested for their antimicrobial and antiseptic 
properties. 
 
3.1. Particle synthesis and aging  
There are a variety of methods used to produce silver nanoparticles. For this study it was 
decided to focus on both chemical and heat production methods. Silver nitrate was used as 
the starting material, which was then reduced and capped with a capping agent of either 
soluble starch, PVP, or citrate depending on the synthesis method being undertaken. 
All chemicals were analytical grade (AR grade) or higher. The chemicals  used were silver 
nitrate (Sigma, S-6506), sodium borohydride (Aldrich,16940-66-2), soluble starch (Chem-
Supply, SA083), polyvinylpyrrolidone (PVP) Mw ~55,000 (Sigma-Aldrich, 856568), tri-sodium 
citrate dehydrated (Chem-Supply, SA034), sodium sulfide nonahydrate (Na₂S) ≥98.0% (Sigma-
Aldrich, 208043), ethylene glycol anhydrous 99.8% (EG)(Sigma-Aldrich, 324558) and mineral 
oil (Sigma-Aldrich, 161403).  
All syntheses were performed using glass 6 drams (24ml) borosilicate vials with paper lined 
plastic caps (Bio-Strategy, WHEA224728) and oval stirring bars with exact dimensions of 
15x6mm (Bio-Strategy, VWRI442-0402).  Disposable spatulas were used, rather than reusable 
spatulas, to limit the silver coating problems identified when producing the silver nitrate 
solution. It was also identified that stirring rates which were too fast or too slow could cause 
sample aggregation.  For this synthesis a stirring speed of 240 rotations per minute (rpm) was 
used throughout the experimental program. 
 
3.1.1. Chemical reduction methods 
In the following methods, sodium borohydride was used as the reducing agent, to reduce 
silver nitrate into elemental silver. The synthesis method then varied depending on the 
desired capping agents used to stabilise the solution.  
Darcy Burns-Dunn, 18018282                                                                                               
22 
 
For the production of silver nanoparticles, it is important to use vials and stirrers which do 
not have silver plating on their surface. Best results were performed with the use of new vials 
and clean stirring rods which were cleaned via sonication (SONICOR, SC-120TH) in ethanol. It 
was also found that if the silver nanoparticles were synthesised with too much light exposure, 
such as a sunny day with the blinds up, it would cause the solution to aggregate. The silver 
nitrate solution preparation was particularly light sensitive; however artificial lighting did not 
seem to have any effect. Foil was used to wrap the solution to prevent light altering the 
solution. Silver nanoparticles were best prepared in the absence of sun light and when the 
solution was wrapped in foil.  
 
3.1.1.1. Starch as the capping agent  
Silver nanoparticles were produced using soluble starch as the capping/stabilising agent(50, 
105). The particles were produced using three starch concentrations and three temperature 
variants and each condition was performed in duplicate. Soluble starch was added at five 
different final concentrations of 1, 5, 10, 50 and 100mg/ml to separate vials (Table 3.1). To 
each vial 5ml of DI water was added and the solution was heated under stirring to either 20°C, 
50°C or 100°C for 20mins. Each of the vials was further delivered 3ml of sodium borohydride 
(4mM) and the vial was again heated for 1min. Following this heating interval, 1ml of silver 
nitrate (2mM) was added to each vial dropwise at a rate of 1.5ml/min. After the addition of 
silver nitrate, the reaction continued for 30seconds before mixing and heating was halted. A 
colour change from a cloudy white to a cloudy yellow was observed for the non-aggregated 
samples. The solution was allowed to sit, in order to let the starch settle down, leaving a clear 
yellow solution and a starch sediment at the bottom of the vial. The final silver concentration 
in this synthesis was 24µg/ml. For this synthesis method it was expecting to produce spherical 
particles with variation in size. 
Table 3.1. Synthesis condition performed in duplicate for the synthesis of silver nanoparticle by chemical 
reduction with starch as the capping agent. 
 
 
 
 
 
Synthesis 
temperature 
Starch concentration and reaction conditions per vial 
1mg/ml 5mg/ml 10mg/ml 50mg/ml 100mg/ml 
20°C 1 2 1 2 1 2 1 2 1 2 
50°C 1 2 1 2 1 2 1 2 1 2 
100°C 1 2 1 2 1 2 1 2 1 2 
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3.1.1.2. PVP as the capping agent 
Silver nanoparticles were also produced using PVP as the capping agent(93). This method 
followed the same procedure as described in section 3.1.1.1. however, PVP is substituted for 
soluble starch. PVP concentrations of 1, 5, 10, 50 and 100mg/ml and synthesis temperatures 
of 20, 50 and 100°C were used. 
 
3.1.1.3. Citrate as the capping agent 
Silver nanoparticles were also produced using citrate as the capping agent  (6, 121). This method 
followed the same procedure as described in section 3.1.1.1. however, tri-sodium citrate was 
substituted for soluble starch. For the synthesis of the citrate capped silver nanoparticles 
citrate concentration of 1, 5, 10, 50 and 100mg/ml were used. This method however was only 
performed at 20°C, due to the sample aggregating at the higher temperatures (results not 
shown). 
 
3.1.2. Heat Reduction method  
In the case of the heat reduction method, silver nanoparticles are produced using 
temperatures of 150°C and 170°C. The high temperatures act as the reducing agent and break 
down the silver nitrate to elemental silver. This was followed by the addition of the capping 
agent to maintain the silver nanoparticles as polydispersed nanoparticles and to prevent 
aggregation (87).  
This synthesis method is also very sensitive to external environments and reaction conditions 
more so than chemical reduction methods(87). The heat reduction method was light sensitive, 
and the best results were obtained with no sunlight and minimal artificial light. This synthesis 
method was also sensitive to silver nitrate plating on the vials and equipment. Best results 
were achived when new vials and magnetic stirrers were used for both synthesis and the 
making of chemicals. The EG used in this synthesis absorbs moisture from the air thus it is 
also important to limit its exposure to air to prevent moisture absorption. 
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The following method was adapted from the work of Skrabalak et al. (87), and was performed 
in a fume hood. EG (5ml) in a capped vial was heated to 150°C or 170°C in a mineral oil bath 
for 1hour with magnetic stirring. For each synthesis new vials and new stirrers were used. A 
solution of PVP was produced with a ratio of 0.03g/1.5ml of EG. The EG solution was added 
first then followed by the addition of the PVP, using a disposable spatula, to prevent loss of 
PVP on the vial walls. PVP sticks to the glass vial and prevents all the PVP from dissolving 
causing variations in concentration. By adding the PVP after the EG, the variation caused by 
the PVP sticking to the glass is minimised. A 1ml solution of 30mM (Na₂S) was prepared 
(0.007g for 1ml). The Na₂S crystals first had to be crushed and weighed to ≈0.007g. Care was 
taken to limit exposure to moisture in these steps. The Na₂S solution was then agitated using 
a vortex. A 10-fold dilution was then made by adding 100ml of this Na₂S solution to 900ml of 
EG to make a 3mM solution, followed by more vortex agitation. Subsequently 80ul of the 
3mM Na₂S solution was then added to the heating vial and heated for 10min. A silver nitrate 
solution was prepared with a ratio of 0.024g/0.5ml EG. The silver nitrate solution was 
wrapped in foil and agitated using a vortex. After the 10min heating period, 1.5ml of PVP 
solution was added, followed by a 0.5ml of the silver nitrate solution. The reaction continued 
for a further 20min. The reaction was successful if a cloudy green to orchard colour was 
achieved. Reaction was quenched by placing vials into a water bath at room temperature. The 
final silver concentration for this synthesis was 1886.7µg/ml. This solution was then diluted 
to match the silver nitrate concentration present in the chemical reduction methods (0.1ml 
of sample was diluted into 8.9ml).  
In the research performed by  Zhang et al. (91)  and Skrabalak et al. (87), who use a similar 
method to that outlined above, recommended a sample washing step involving centrifugation 
with water or acetone and resuspending in DI water via sonication. This was performed and 
imaged via the SEM to determine the effect of this rinsing step. 
 
3.1.3. Aging of the silver nanoparticles samples  
Some of the sample volume were used for immediate testing however the remaining sample 
volume was aged for one week. All the samples were aged in their original vials. These vials 
were placed in a water bath (Julabo, SW22) at 20°C and aged for one week. Vials in the water 
bath were exposed to artificial light only. 
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3.2. Characterisation of nanoparticles 
The first step in characterising the silver nanoparticles was simply observational, identifying 
the colour of the sample and photograph them.  
The samples were read via ultraviolet visible spectroscopy (UV-vis) in a Shimadzu UV-2600 
Series. The silver nanoparticle samples were measured from wavelength 300 - 800nm at 
0.5nm wavelength intervals. The UV-vis was baselined using 3ml of Milli-Q water in a cuvette. 
Three millimetres of the silver nanoparticle sample was added to a cuvette and a sample 
absorbance was taken following the protocol outlined above. The raw absorbance data were 
exported to Excel and data scaled so that the lowest absorbance was zero. A peak absorbance 
between 390nm and 430nm indicates the presence of nanoparticle silver while the peak 
width at half maximum (PWHM) gives an indication of the particle size(88). 
The structural properties of each silver nanoparticle sample were then observed using 
scanning electron microscopy in a Zeiss MERLIN STEM.  For each silver nanoparticle sample 
2µl of sample was placed onto a silicon wafer (approximately 0.5cm²). This was left to dry 
completely in a fume hood. The silicon wafer containing the dried silver sample, was then 
adhered, using a carbon sticky tab, to a SEM stub. The stubs were placed under vacuum for 
30min to remove any residual moisture from the sample. The samples were then loaded into 
the SEM. The SEM images were taken using a ZEISS MERLIN compact VP-60-09 at 5kV. Images 
were taken at multiple magnifications in multiple different areas of the samples. 
The images obtained from the SEM were then analysed using ImageJ software. In this 
program the image was set to scale and individual silver nanoparticles were measured. For 
each sample condition, and its duplicate, 100 to 150 individual nanoparticles were counted 
and measured. These results were then averaged and a standard deviation (SD) was produced 
to determine average particle size and size distribution. 
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3.3. Antimicrobial activity 
3.3.1. Media and sterilisation 
Nutrient broth (CM0001), malt extract broth (CM0057) and agar (LP0013) were all purchased 
from Oxoid and prepared following manufacturer’s instructions. Two types of slopes were 
prepared one with 13g/L nutrient broth and 1.2%(w/v) agar and the other with 20g/L malt 
broth and 1.2%(w/v) agar and both were sterilised at 120°C for 15 minutes. The sterile and 
homogeneous solution was then distributed into McCartney bottles and sterilised again 
(120°C for 15 minutes). The slopes were then allowed to cool and set on a slanted rack. 
Further, two types of agar plates were prepared, one with 13g/L nutrient broth and 1.2%(w/v) 
agar and the other with 20g/L malt broth and 1.2%(w/v) agar and sterilised at 120°C for 15 
minutes. The hot solution was cooled to 50°C and poured into a sterile Petri dish, care was 
taken to limit time that dishes were without a lid. The agar was left to set then immediately 
used, or sealed and stored at 4°C. Sterile nutrient broth at 13g/L and malt broth at 20g/L were 
also prepared and sterilised at 120°C for 15 minutes. 
 
3.3.2. Bacterial strains 
The antimicrobial effects of the synthesised silver nanoparticles were tested against four 
microorganisms, Pseudomonas aeruginosa 377, Escherichia coli 185, Staphylococcus aureus 
184 and Candida albicans X26. Each culture was obtained from the Western Sydney Culture 
collection. Bacterial cultures are maintained on nutrient agar slopes and malt extract agar 
slopes were used for fungus (C. albicans). All slopes were incubated at 37°C for 24 hours then 
stored in a fridge at 4°C. Twenty-four hours prior to conducting the experiment the four 
microbial cultures were inoculated into a sterile nutrient broth for the bacteria and malt 
extract broth for the fungus. The inoculated broths were then incubated at 37°C for 24hours. 
Inoculation was performed by aseptic transfer of a loop full of the bacterial culture.  
 
3.3.3. Minimum inhibitory concentration. 
Each overnight culture was diluted by 10³ in sterile broth solution to produce a solution 
containing approximately 10⁶ cfu/ml. To perform a minimum inhibitory concentration (MIC) 
a CellStar (Greiner bio-one) sterile flat bottom 96-well plates was used. The plates were set 
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up as described in Figure 3.2. To each well of the 96-well plate 100µl of broth was added and 
an additional 100µl of broth was added to the wells in column 12, making it the negative 
control. To the wells in columns 1 and 6, 100µl of the desired silver nanoparticle sample was 
added. The contents of the wells were mixed and 100µl was removed and mixed with the 
next column along, e.g. from column 1 to column 2. This was repeated for all the wells across 
the plate resulting in 5 serial 2-fold dilutions. 100µl was removed and discarded from the final 
well at 5 and 10. Subsequently 100µl of diluted overnight culture was added to the wells in 
columns 1-11. The final silver concentration in each well were 12, 6, 3, 1.5 and 0.75µg/ml for 
sequential dilutions (Figure 3.1). The plate was then placed in an incubator at 37°C for 24 
hours. After the incubation period the plate absorbance was read via a CLARIOstar plate 
reader. The plate was read at an excitation of 595nm with a scanning width of 4mm and a 3 x 
3 scanning matrix. The absorbance readings were converted to an Excel document using 
MARS software and were analysed in Excel. First the averages for the controls were 
determined and the average of the negative control was subtracted from each sample. The 
samples were then averaged and converted to a percentage growth of the positive control. 
The MIC was then identified as the lowest concentration giving an average microbial growth 
less than 10% of the positive control.  The layout of the plates is shown in Figure 3.1. 
 
 
 
 Sample duplicate 1 Sample duplicate 2 Positive 
control  
Negative 
control 
Silver 
nanoparticle 
sample A 
12 6 3 1.5 0.75 12 6 3 1.5 0.75 A A 
12 6 3 1.5 0.75 12 6 3 1.5 0.75 A A 
12 6 3 1.5 0.75 12 6 3 1.5 0.75 A A 
12 6 3 1.5 0.75 12 6 3 1.5 0.75 A A 
Silver 
nanoparticle 
sample B 
12 6 3 1.5 0.75 12 6 3 1.5 0.75 B B 
12 6 3 1.5 0.75 12 6 3 1.5 0.75 B B 
12 6 3 1.5 0.75 12 6 3 1.5 0.75 B B 
12 6 3 1.5 0.75 12 6 3 1.5 0.75 B B 
 Silver nanoparticle concentrations (µg/ml)   
Figure 3.1. The setup on the CellStar used to perform the MIC, showing the final silver concentration for each 
sample. 
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3.3.4. Minimum bactericidal concentration 
To test the bactericidal and fungicidal properties of the silver nanoparticles a Minimum 
Bactericidal/Fungicidal Concentration (MBC/MFC) test was conducted(47). In this test the 
samples from section 3.3.1. which were able to inhibit 90% of bacterial growth were used for 
the MBC. The MBC was performed by streaking the samples onto a nutrient agar plate for the 
bacteria and a malt broth agar plate for the fungus. For each sample, and sample 
concentration, four replicates were performed. The plates were then placed in an incubator 
at 37°C for 24 hours. Following the incubation period, the MBC/MFC was identified as the 
lowest silver nanoparticles concentration at which no bacterial or fungal growth was 
observed on the agar plate for all four replicates.  
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Chapter 4. Results  
The morphology and size distributions of nanoparticles synthesised by chemical and heat 
reduction methods were examined before determining their antimicrobial properties. During 
the synthesis of the nanoparticles, the colour of each sample was monitored and in instances 
where the observed colour changed from clear to grey/black the sample was discarded. 
Where the synthesis resulted in observable gold/yellow colours the products of the reaction 
were kept, and nanoparticles were analysed immediately using UV-vis spectrometry to 
identify whether silver nanoparticles were present. Samples were also imaged using SEM to 
provide confirmation of nanoparticle size and shape. Following this analysis if the sample 
showed evidence of silver aggregation the sample was not explored further. The 
nanoparticles observed via the SEM were measured to determine average particle size, 
morphology and size distribution. The antimicrobial activity of the particles against a panel of 
test microorganisms was then determined by conducting MICs and MBCs.  
 
4.1. Synthesis of Nanoparticles by Chemical Reduction Methods 
This section presents the results from the synthesis of silver nanoparticles via the chemical 
reductions method outlined in section 3.1.1. The reduction of silver nitrate to silver was 
induced by sodium borohydride at a ratio of 1:2. The synthesis was then capped and stabilised 
using either soluble starch or PVP at varying concentrations of 1, 5, 10, 50, 100mg/ml.  
 
4.1.1. Starch as the capping agent 
Variation in the concentration of starch can be used to produce silver nanoparticles and to 
prevent particle aggregation. It was found that a starch concentration between 5mg/ml and 
50mg/ml produced the colour characteristic of silver nanoparticles (Figure 4.1) (Section 
3.1.1.1). At 1mg/ml the sample demonstrated a visible grey/black colour, indicating 
aggregation and at 100mg/ml there was no visible colour change indicating that the synthesis 
had been completely inhibited. This pattern was consistent irrespective of the synthesis 
temperature being 20°C, 50°C, or 100°C. The 1mg/ml and 100mg/ml concentrations were 
excluded from subsequent analysis.  
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Figure 4.1. Silver nanoparticles synthesised via chemical reduction with starch as the capping agent. Variation 
in colour observed for starch concentrations of 1, 5, 10, 50 and 100mg/ml at 20°C. 
 
The starch capping concentrations of 5, 10, and 50mg/ml samples were synthesised at 20°C, 
50°C, and 100°C. Temperature plays a role in inhibiting the formation of nanoparticles with a 
starch capping agent and this is evident on the UV-vis results (Figure 4.2).  At 20°C 
temperature a peak was evident in all samples between 401 – 408 nm range with a shift 
towards higher wavelengths as starch concentration increases. At 50°C a discernible peak was 
evident at starch concentrations of 5 and 10mg/ml but not at 50mg/ml. At the maximum 
temperature of 100°C a discernible peak was only evident at the 5mg/ml starch 
concentrations.  
Figure 4.2. UV -vis data for silver nanoparticles produced via chemical reduction method with starch as the 
capping agent. Samples prepared at varying temperature (20, 50 and 100°C) and starch concentration (5, 10 
and 50mg/ml) were tested. Additional data in Appendix 1. 
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At 20°C, 50°C, and 100°C the 5mg/ml starch concentration had a discernible peak, however 
this peak shifted to a longer wavelength with increasing reaction temperature, going from 
401.5 at 20°C to 409.5 at 100°C (Figure 4.2). This trend was also observed at 10mg/ml were 
the peak shifted from 405nm at 20°C to 411nm at 50°C. For the 50mg/ml starch concentration 
the only peak observed was with particles synthesised at 20°C. 
As shown in Table 4.1 the 20°C synthesis temperature and low starch concentration resulted 
in the lowest peak wavelength and the smallest peak width at half maximum (PWHM). The 
PWHM increased in response to changes in temperature and starch concentration. At the 
5mg/ml peak, the width increased with increasing temperatures.  At 20°C the peak, the width 
was 60-65nm, at 50°C 75-81nm and at 100°C peak width was 83-126nm.  The results show 
that as temperature and concentration increase so does the peak width, which is indicative 
of an increase in particle size. 
Table 4.1. Silver nanoparticle peak wavelengths and peak width at half maximum (PWHM) obtained from the 
UV-vis data provided in Figure 4.2 and Appendix 1. 
Synthesis 
temperature 
Capping agent 
concentration 
Duplicate Peak wavelength (nm) PWHM (nm) 
20°C 
5mg/ml 
1 401.5 60 
2 402.5 65 
10mg/ml 
1 405 67 
2 405.5 67 
50mg/ml 
1 408 93 
2 408.5 90 
50°C 
5mg/ml 
1 407.7 81.5 
2 407 75.5 
10mg/ml 
1 411.5 89 
2 411 92 
50mg/ml 
1 No peak NA 
2 No peak NA 
100°C 
5mg/ml 
1 409.5 82 
2 409 83 
10mg/ml 
1 No peak NA 
2 No peak NA 
50mg/ml 
1 No peak NA 
2 No peak NA 
 
The morphology of the silver nanoparticles by chemical reduction with starch as the capping 
agent changed over the varying condition. The images in Figure 4.3 and Appendix 2 show the 
changes in morphology of the silver nanoparticles when synthesis temperature was altered 
or as starch concentration was changed. Particles produced at 20°C were predominately cubic 
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in shape with limited spherical particles. At a synthesis temperature of 50°C the cubic 
nanoparticles became more rounded and the number of spheres increased. When the 
particles were synthesised at 100°C all three concentrations showed some particle 
aggregation, with small spherical particles observed amongst the aggregated masses. The 
shape of the starch capped silver nanoparticles showed temperature dependence. 
 
 
Figure 4.3. Silver nanoparticles with varying temperatures and starch concentrations. All photos at 100,000x 
magnification at 5kV. Scale bar at 200nm (bottom right corner). Additional images in Appendix 2.  
 
 
Average particle size was determined for each synthesis condition by measuring individual 
particles using the images obtained from the SEM and using ImageJ to measure the 
nanoparticles(48, 90). For each sample 100 to 150 individual particles were measured for 
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duplicate samples for each synthesis condition. The results of this are presented in Figures 
4.4 – 4.6. Figure 4.4 contains all the results of the synthesis at 20°C, Figure 4.5 contains those 
synthesised at 50°C and Figure 4.6 contains the test at 100°C. 
Figure 4.4. Analysis of the synthesis at 20°C SEM images collected for duplicate samples. The histograms show 
the particle size and size distribution of a single sample (n100-150). From these measurements the average size 
and standard deviation (SD) were determined and presented. Of the measured particles, shape was determined 
and presented as a percentage. 
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Figure 4.5. Analysis of the synthesis at 50°C SEM images collected for duplicate samples. The histograms show 
the particle size and size distribution of a single sample (n100-150). From these measurements the average size 
and standard deviation (SD) were determined and presented. Of the measured particles, shape was determined 
and presented as a percentage.  
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Figure 4.6. Analysis of the synthesis at 100°C SEM images collected for duplicate samples. The histograms show 
the particle size and size distribution of a single sample (n100-150). From these measurements the average size 
and standard deviation (SD) were determined and presented. Of the measured particles, shape was determined 
and presented as a percentage. 
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Synthesis of silver nanoparticles with variable starch concentrations and a synthesis 
temperature of 20°C resulted in a particle size range between 100nm and 160nm in all 
samples (Figure 4.4). The standard deviations ranged from 40 to 90nm and increased in 
relation to increasing starch concentrations. The percentage of cubic shape ranged from 70% 
to 80% at the lower synthesis temperatures of 20°C. However, as starch concentration 
increased there was an increase in the percentage of irregular shapes. Irregular shape 
percentage increased slightly at greater starch concentrations at a synthesis temperature of 
20°C. The sample irregular shape percentage went from 0% at 5mg/ml to 5-6% at 50mg/ml. 
For the synthesis of silver nanoparticles at 20°C the particle sizes did not alter regardless of 
starch concentration and the majority of particles were cubic. 
At synthesis temperatures of 50°C and concentrations of 5mg/ml the particles had a mean 
size of 32nm for duplicate 1 and 33nm for duplicate 2 each having a slight variation in standard 
deviation of 25nm to 37nm (Figure 4.5). These synthesis conditions produced the smallest 
particles and the smallest particle variation. At 50°C with increased starch concentration to 
10mg/ml the synthesised particles had an average size of 224nm for duplicate 1 and 206nm 
for duplicate 2 and a slight size deviation existed. The SD was greater for the 10mg/ml than 
the 5mg/ml. When the starch concentration was increased to 50mg/ml the nanoparticles 
were similar to the 10mg/ml in size being 264nm for duplicate 1 and 181nm for duplicate 2. 
Again, slight SDs existed, however the SD at 50mg/ml was larger again than at 10 or 5mg/ml. 
For the synthesis of silver nanoparticles at 50°C at different starch concentrations the mean 
particle size and SD increased with the increase in starch concentration. The shape of the 
majority of silver nanoparticles produced at 50°C was spherical (66%) with an average 
percentage of cubic shapes was only nine percent. At a synthesis temperature of 50°C the 
silver nanoparticles were spherical in shape with an increased average nanoparticles size as 
starch concentration increased. 
At synthesis temperatures of 100°C the average particle size showed no trend associated with 
the starch concentration (Figure 4.6). All samples showed a particle average size between 
226nm and 354nm. Standard deviations were higher for all samples at 100°C ranging from 
121nm to 381nm. The major shape type present in the samples synthesised at 100°C were 
irregular in shape, making up 84-92% of each sample. Only 0-4% of the sample was made up 
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of cubic shaped nanoparticles. All the silver nanoparticles produced at 100°C were large and 
irregularly shaped with a broad size spectrum greater than 226nm. 
For the synthesis of silver nanoparticles using chemical reduction, with starch as the capping 
agent, lower temperatures showed a higher percentage of cubic particles at the larger range 
of 100nm to 160nm. At 50°C the samples demonstrated a higher proportion of spherical 
particles, whereas at 100°C the majority of the samples were made up of large but also 
irregularly shaped particles (208-354nm). The smallest particles were synthesised at 50°C with 
a starch concentration of 5mg/ml (32 and 33nm); this synthesis condition also resulted in the 
least size variation. The above results show a large contrast between the characteristics of 
the synthesised particles according to their synthesis conditions. 
 
4.1.2. PVP as capping agent 
PVP is a soluble polymer often used in the production of silver nanoparticles. Silver 
nanoparticles were synthesised in duplicate over a range of temperatures and PVP 
concentrations. It was found that the PVP concentrations of 5mg/ml and 10mg/ml produced 
the characteristic gold/yellow colour of silver nanoparticles, with 1mg/ml resulting in a 
darkening of the solution suggesting aggregation and 50mg/ml and 100mg/ml demonstrating 
darkening with shades of yellow suggesting prevention of nanoparticle synthesis (Figure 4.7). 
 
Figure 4.7. Silver nanoparticles synthesised via chemical reduction with PVP as the capping agent. PVP was 
tested at concentrations of 1, 5, 10, 50 and 100mg/ml at 20°C. 
 
The UV-vis data presented in Figure 4.8 shows the UV-vis peaks of each of the synthesis 
conditions. A representative peak was selected from the duplicates and the full set of results 
is presented in Appendix 3. The results clearly show that 20°C produced the strongest or 
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highest peaks with a slight shift to a higher wavelength with increased PVP concentration. At 
a synthesis temperature of 50°C, a peak was seen at 5mg/ml PVP but no peak at 10mg/ml. 
The synthesis at 100°C showed no peaks. Table 4.8. shows the UV-vis data in written form of 
both duplicates. Variation between duplicates was minimal. All test samples presented a peak 
width at half maximum in the range 67 to 80.5nm. Synthesis of silver nanoparticles with PVP 
showed a trend of reduced peaks with increased synthesis temperature. 
 
Figure 4.8. UV -vis data for silver nanoparticles produced via chemical reduction method with PVP as the 
capping agent. Samples prepared at varying temperature (20, 50 and 100°C) and PVP concentration (5, 10 and 
50mg/ml) were tested. Additional data in Appendix 3. 
 
Table 4.2. Silver nanoparticle peak wavelengths and peak width at half maximum (PWHM) obtained from the 
UV-vis data provided in Figure 4.8 and Appendix 3. 
Synthesis 
temperature 
Capping agent 
concentration 
Duplicate Peak wavelength (nm) PWHM (nm) 
20 
5mg/ml 
1 408 72 
2 407 70 
10mg/ml 
1 410 70.5 
2 411 75.5 
50 
5mg/ml 
1 408.5 80.5 
2 406 67 
10mg/ml 
1 No peak NA 
2 No peak NA 
100 
5mg/ml 
1 No peak NA 
2 No peak NA 
10mg/ml 
1 No peak NA 
2 No peak NA 
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Duplicate samples of all three synthesis temperatures (20, 50 and 100°C) and both 
concentrations (5 and 10mg/ml) were investigated using SEM and results are shown in Figure 
4.8. At 20°C most of the observed particles were spherical in shape. The particles synthesised 
at a concentration of 10mg/ml were generally smaller in majority, however some large 
aggregates were also present. For particles synthesised at 50°C the PVP concentration 
resulted in more variation in shape. At a concentration of 5mg/ml the particles appeared 
more angular with some becoming cubic. However, at 10mg/ml the sample was still largely 
made up of spherical particles and some irregular particles. At 100°C the particles become 
much more cubic in shape at PVP concentrations of 5mg/ml. At 10mg/ml of PVP however, the 
samples were comprised almost completely of spherical shaped particles. The results of the 
Figure 4.9. Silver nanoparticles with varying temperatures and PVP concentrations. All photos at 100,000x 
magnification at 5kV. Scale bar at 200nm (bottom right corner). Additional images in Appendix 4. 
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SEM in Figure 4.9 showed a trend between increased synthesis temperature and an increase 
in cubic particle formation. At the higher concentration (10mg/ml) the particles were 
consistently spherical in their majority.  
Again, average particle size, size standard deviation and shape percentages were determined 
using measurements obtained from the SEM images. Figure 4.10 shows the results for the 
silver nanoparticles synthesised using PVP at 20°C. The average particle size was slightly larger 
at 58nm and 43nm for the lower PVP concentration of 5mg/ml in both duplicates 1 and 2, 
whereas at 10mg/ml it was 29nm and 34nm. The standard deviation for 5 and 10mg/ml were 
similar, with ranges between 12nm to 30nm. Percentage of irregular shapes increased with 
increased PVP concentration from <1% and 1% at 5mg/ml to 12% and 8% at 10mg/ml. The 
synthesis of silver nanoparticles via PVP at 20°C produces small spherical particles and PVP 
concentrations of 10mg/ml produced particles that were smaller and more irregular. 
Figure 4.10. Analysis of the synthesis at 20°C SEM images collected for duplicate samples. The histograms show 
the particle sizes morphology and size distribution of a single sample (n100-150). From these measurements 
the average size and standard deviation (SD) were determined and presented. Of the measured particles, shape 
was determined and presented as a percentage. 
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When the silver nanoparticles were synthesised using PVP at 50°C, contrary to the results at 
20°C, the larger average particle sizes were present at 10mg/ml and the smaller at 5mg/ml 
(Figure 4.11). The average particle size was 37nm and 42nm at 5mg/ml and 66nm and 76nm 
at 10mg/ml. The standard deviations were also higher at 10mg/ml, at 17nm and 28nm for 
5mg/ml and 49nm and 33nm for 10mg/ml. At PVP concentration of 5mg/ml a smaller 
percentage of cubes was observed (2 and 8%). Also, at 5mg/ml the percentage of irregular 
shapes increased compared to the percentage for 20°C, increasing to 10% at 50°C where it 
was 1% at 20°C. While at 50°C the majority of the sample is made up of spherical particles 
and other shapes begin to form. 
Figure 4.11. Analysis of the synthesis at 50°C SEM images collected for duplicate samples. The histograms show 
the particle sizes morphology and size distribution of a single sample (n100-150). From these measurements 
the average size and standard deviation (SD) were determined and presented. Of the measured particles, shape 
was determined and presented as a percentage. 
When the synthesis temperature was increased to 100°C the average particle size at 5mg/ml 
was 73nm and 78nm (Figure 4.12). At 10mg/ml the average size was 37nm and 38nm. The 
standard deviations for 5mg/ml at 100°C were slightly wider than at 10mg/ml at 100°C, at 43 
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and 40nm for 5mg/ml and 32 and 21nm for 10mg/ml. For the synthesis at 100°C cubes were 
only observed at 5mg/ml PVP concentration, not at 10mg/ml. For the synthesis of silver 
nanoparticles with PVP at 100°C, low concentration of PVP slightly promote the formation of 
cubic particles. 
Figure 4.12. Analysis of the synthesis at 100°C SEM images collected for duplicate samples. The histograms 
show the particle sizes morphology and size distribution of a single sample (n100-150). From these 
measurements the average size and standard deviation (SD) were determined and presented. Of the measured 
particles, shape was determined and presented as a percentage. 
In summary, when synthesising silver nanoparticles via a chemical reduction method using 
PVP as the capping agent the concentration of PVP and synthesis temperature influenced the 
particles characteristics. For the concentration of 5mg/ml of PVP over the three temperatures 
average particle size stayed the same at 20 and 50°C but became larger at 100°C. At a PVP 
concentration of 10mg/ml average nanoparticle size remained similar with a slightly larger 
size at 50°C. For 5mg/ml concentrations, cubic particle percentage increased with increasing 
temperatures. However, for all silver nanoparticle samples produced with PVP, the most 
abundant shape was spherical. 
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4.1.3. Citrate as the capping agent 
Citrate in the form of sodium citrate is often used as a capping agent in silver nanoparticle 
production. The citrate capped silver nanoparticles were synthesised only at 20°C otherwise 
the silver sample became a dark grey indicating aggregation. The silver nanoparticles capped 
with citrate were synthesised at 5 different concentrations; being 1, 5, 10, 50 and 100mg/ml. 
The suspension prepared at a citrate concentration of 50mg/ml showed the least aggregation 
and colour closest to being characteristic of silver nanoparticles (Figure 4.13). At a 
concentration of 10mg/ml, or less, the sample aggregated and at 100mg/ml no reaction 
occurred. 
 
Figure 4.13. Silver nanoparticles synthesised via chemical reduction with citrate as the capping agent. Citrate 
concentration were altered to 1, 5, 10, 50 and 100mg/ml and variation in colour were observed. 
 
 
Figure 4.14. UV -vis data for silver nanoparticles produced via chemical reduction method with citrate as the 
capping agent. Samples prepared at a synthesis temperature of 20°C and citrate concentration of 50mg/ml 
were tested. 
 
Darcy Burns-Dunn, 18018282                                                                                               
44 
 
Table 4.3. Silver nanoparticle peak wavelengths and peak width at half maximum (PWHM) obtained from the 
UV-vis data provided in Figure 4.14. 
Synthesis 
temperature 
Capping agent 
concentration 
Duplicate Peak wavelength (nm) PWHM (nm) 
20 50mg/ml 
1 No peak NA 
2 419 102 
 
The UV-vis results gave no peak for duplicate 1 and only a small peak at 419nm for duplicate 
2. This peak had a PWHM of 102nm. The results of the SEM showed the silver suspension 
aggregating when synthesised under chemical reduction with citrate as the capping agent at 
a concentration of 50mg/ml at 20°C (Figure 4.15). Particles are large and irregular and can be 
seen forming into a mass. 
 
 
Figure 4.15. Silver nanoparticles produced via chemical reduction with citrate as the capping agent at a 
concentration of 50mg/ml at 20°C in duplicate. All photos were taken on a ZEISS MERLIN compact VP-60-09 
SEM at 100,000x magnification at 5kV with an InLens. Scale bar at 200nm (top right corner).  
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4.2. Heat Reduction Method 
This section presents the results of the silver nanoparticles synthesised using a heat reduction 
method described in section 3.1.2. In this method silver nitrate reduction was stimulated 
using very high temperatures. EG was used as a solvent in this synthesis to prevent it boiling 
or becoming a gas(102). PVP was again used as the capping/stabilising agent. This synthesis 
method is also very sensitive to external environments and reaction conditions. A 
polydisperse and non-aggregated sample was achieved when new EG was used (Figure 4.16). 
Furthermore, the sample was affected during rinsing steps, it was found that a raw or simply 
diluted sample produced a non-aggregated sample. For the synthesis of silver nanoparticles 
via the heat reduction method two temperatures were tested, 150°C and 170°C. 
 
 
Figure 4.16. Shows a good representative image of silver nanoparticles that have had no rinsing stage but have 
been simply diluted with DI water. The image on the bottom left has been synthesised using old EG. The image 
on the bottom middle has been rinsed using DI water (rinsing involves spinning down and resuspending the 
sample). The image on the bottom right is a sample that has been first rinsed with acetone then DI water. Scale 
bars vary for each image, see image for associated scale bar.  
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Figure 4.17. UV-vis data extracted from the silver nanoparticles produced via heat reduction method and their 
associate solutions. Samples of varying temperature (150 and 170°C) were tested. Tests were performed on 
duplicate samples however only one represented duplicate has been provided, see Appendix 5 for full result. 
 
The UV-vis data from the two synthesis temperatures (150 and 170°C) using the heat 
reduction method show two very different peaks. At 150°C the peak was very narrow, and 
both peaks were similar with duplicate 1 at 408nm and 2 at 408.5nm (Figure 4.17 and Table 
4.4). The peak width at half maximum was 40.5nm and 45.5nm for duplicate 1 and 2 
respectively. The peaks produced at 170°C were at 509 and 449nm and were very wide, 
producing peak widths of 292.5 and 290nm for duplicate 1 and 2 respectively. The synthesis 
at 170°C also showed a bump at 350nm. The result of the UV-vis showed that the increased 
in synthesis temperature from 150°C to 170°C produced nanoparticles with very different 
characteristics. 
 
Table 4.4. Silver nanoparticle peak wavelengths and peak width at half maximum (PWHM) obtained from the 
UV-vis data provided in Figure 4.17 and Appendix 5. 
Synthesis temperature Replicate 
Peak wavelength 
(nm) 
PWHM 
(nm) 
150°C   
1 408 40.5 
2 408.5 45.5 
170°C   
1 509 292.5 
2 449 290 
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For the 150°C synthesis temperature the nanoparticles were very small and spherical in shape 
(Figure 4.18). At the 170°C synthesis temperature the particles were much larger and rod-
shaped particles were present. The histograms produced via the SEM images for both 
duplicates further showed this difference in particle characteristics (Figures 4.19). For the 
synthesis at 150°C both duplicates gave an average particle size of 8nm with standard 
deviation of 5 and 3nm for duplicate 1 and 2 respectively. This is the smallest standard 
deviation for all synthesis methods reported in this thesis. This synthesis method produced a 
very uniform product at 150°C.  At 170°C the average particle size is larger at 64 and 71nm. 
At the synthesis temperature of 150°C the sample was 96% and 94% made up of spherical 
particles, with the rest being irregularly shaped. However, at 170°C the sample showed large 
percentages of rod-shaped particles with 41% and 39% for duplicate 1 and 2 respectively. The 
SEM images for the two synthesis temperatures (150 and 170°C) using the heat reduction 
method presented in Figure 4.19, showed large differences between the synthesis 
temperatures, where 150°C had smaller spherical particles and at 170°C had larger rod-
shaped particles. 
 
 
Figure 4.18. Silver nanoparticles with heat reduction and varying synthesis temperatures. All photos at 
100,000x magnification at 5kV. Scale bar at 200nm (bottom right corner). Additional images in Appendix 6 
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Figure 4.19. Analysis of the synthesis at 150 and 170°C via heat reduction SEM images collected for duplicate 
samples. The histograms show the particle size morphology and size distribution of a single sample (n100-150). 
From these measurements the average size and standard deviation (SD) were determined and presented. Of 
the measured particles, shape was determined and presented as a percentage. ‘*’ indicated were average rod 
length was also determined. 
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4.3. Chemical reduction method, 1 week aged  
The silver nanoparticles synthesised using the chemical reduction method were aged for 7-
days. The aged samples were then again explored using UV-vis, SEM, MIC and MBC. The 
results between new and aged samples could then be compared.  
 
4.3.1. Starch as capping agent 
The syntheses of silver nanoparticles using the chemical reduction method and starch as the 
capping agent after one-week of aging produced the UV-vis output presented in Figure 4.20 
and Table 4.5. Figure 4.20 contains the UV-vis data graphs of a single representative duplicate 
while Table 4.5 presents the data from both replicates. Low synthesis temperature and low 
starch concentration produced the lowest peak wavelength (403 and 402nm) and the 
smallest PWHM (62 and 59nm). In the 20°C samples the peak wavelength increased with 
increasing starch concentration from 402nm to 405nm to 407nm for concentrations of 
5mg/ml, 10mg/ml and 50mg/ml respectively. At 50°C a similar change was observed with 
wavelength increasing from 407.5nm and 408nm at 5mg/ml to 412nm and 409.5nm at 
10mg/ml. Peak wavelength also increased with increasing temperature, at a concentration of 
5mg/ml increasing from 402 and 403nm at 20°C to 408 and 407.5nm at 50°C and then 410 
and 410.5 at 100°C. The UV-vis results of the silver nanoparticles synthesised via chemical 
reduction with starch as the capping agent after a week of aging showed the same trends as 
observed with the fresh sample. An increase in peak wavelength was found with the increase 
of concentration and temperature. 
The results of the PWHM obtained from the UV-vis of the starch capped silver nanoparticles 
produced via chemical reduction showed the expected result. At 20°C the PWHM increased 
with increasing starch concentration from 62 and 59nm at 5mg/ml, 66nm at 10mg/ml to 79 
and 83nm at 50mg/ml. The same trend was observed at 50°C increasing from 86 and 78nm 
at 5mg/ml to 103 and 117nm at 10mg/ml. Further 100°C showed the same trend increasing 
from 84 and 86nm at 5mg/ml to 137 and 133nm at 10mg/ml. The PWHM also increased with 
increasing temperature, at a starch concertation of 5mg/ml the PWHM was 62 and 59nm at 
20°C, 86 and 78nm at 50°C and then 84 and 86nm at 100°C. The synthesis of silver 
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nanoparticles via chemical reduction with starch as the capping agent produced nanoparticles 
with a PWHM that increased in width with increasing temperature and starch concentration. 
 
Table 4.5. Silver nanoparticle peak wavelengths and peak width at half maximum (PWHM) obtained from the 
UV-vis data provided in Figure 4.1.1.1 and Appendix 7. 
Synthesis 
temperature 
Capping agent 
concentration 
Duplicate Peak wavelength (nm) PWHM (nm) 
20°C 
5mg/ml 
1 403 62 
2 402 59 
10mg/ml 
1 405.5 66 
2 406 66 
50mg/ml 
1 407 79 
2 406.5 83 
50°C 
5mg/ml 
1 408 86 
2 407.5 78 
10mg/ml 
1 412 103 
2 409.5 117 
50mg/ml 
1 No peak NA 
2 No peak NA 
100°C 
5mg/ml 
1 410.5 84 
2 410 86 
10mg/ml 
1 409.5 137 
2 411 133 
50mg/ml 
1 No peak NA 
2 No peak NA 
Figure 4.20. UV-vis data extracted from the silver nanoparticles produced via chemical reduction method with starch as the capping 
agent and aged for 1 week. Samples of varying temperature (20, 50 and 100°C) and starch concentration (5, 10 and 50mg/ml) were 
all tested. Tests were performed on duplicate samples however only one represented duplicate has been provided, see Appendix 7 for 
full result. 
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The results of the SEM images for the silver nanoparticles produced via chemical reduction 
with starch after a week aging period are shown in Figure 4.21. Duplicate samples were tested 
for each synthesis condition however only a single representative image is provided in Figure 
4.21. These images show an association between increased starch concentration and 
increasing particle size, with the exception of 50mg/ml at 50°C. The particles synthesised 
using the 5mg/ml were small and spherical while those at 10mg/ml are larger and more 
angular. At 50mg/ml the sample synthesised at 100°C were aggregated whereas those at 50°C 
and 20°C were large and angular. The samples synthesised using chemical reduction with 
starch as the capping agent after a week of aging became more angular and larger with 
increasing concentration of starch.  
 
 
Figure 4.21. Silver nanoparticles with varying temperatures and starch concentrations after 7-days of aging. All 
photos at 50,000x magnification at 5kV. Scale bar at 200nm (bottom right corner). Additional images in 
Appendix 7. 
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For the sample synthesised at 20°C and aged for a week the nanoparticle samples showed 
spheres, cubes and irregularly shape particles (Figure 4.21) present. At a synthesis 
temperature of 100°C the week aged sample had limited aggregation at the lower starch 
concentrations (5 and 10mg/ml) but lots of aggregation at the high starch concentration 
(50mg/ml). The above synthesised silver nanoparticles showed a difference in particle 
characteristics over the different starch concentrations.  
The SEM Images from the silver nanoparticles produced via chemical reduction with starch as 
the capping agent after being aged for a week were further analysed and the results 
presented in Figures 4.22 – 4.24. The results of the synthesis at 20°C are presented in Figure 
4.22. Particle size remains similar at the 5 to 10mg/ml concentrations, producing averages in 
the range of 19-46nm but then jumps drastically at the 50mg/ml starch concentration to 117 
and 154nm. The SDs were larger for the synthesise with 50mg/ml starch giving 157 and 
201nm. Whereas at the lower starch concentration the SDs were much smaller at 18 and 
15nm for 5mg/ml and 33 and 34nm for 10mg/ml. The samples synthesised with 5 and 
10mg/ml of starch showed majority spherical particles at percentages of 64-97%. The 
remaining percentage was mostly made up of cubic particles at 12-23% with 5mg/ml having 
the a slightly greater cubic percentage of 22 and 23% while 10mg/ml had 12%. At 50mg/ml of 
starch the majority were irregular in shape at 66 and 79%, with the largest remaining 
percentages being spherical particles at 20 and 34%. The synthesis of the starch capped and 
chemically reduced silver nanoparticles, at synthesise temperature of 20°C, and after a week 
of aging, the nanoparticles were larger and more irregular with increasing starch 
concentration. 
For the synthesis of silver nanoparticles using starch at a 50°C synthesis temperature the 
samples appeared only slightly different despite starch concentration differences (Figure 
4.23). All nanoparticle size averages were within 22 and 68nm. The smallest average particle 
size was produced with a starch concentration of 10mg/ml at 22 and 29nm. Then at 50mg/ml 
with 38 and 42nm, with the largest sized nanoparticles found at 5mg/ml of 40 and 68nm. The 
SDs for the 50°C syntheses were smallest for 10mg/ml, at 9 and 12nm. For starch 
concentrations at 5mg/ml and 50mg/ml the SDs became slightly greater in the range of 14-
46nm. The shape majority at 50°C synthesis temperature was spherical for all samples at each 
starch concentration, being between 60 and 82%. The remaining percentage was mostly 
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made up with irregular shapes at 12 to 25%. For the synthesis of silver nanoparticles using the 
chemical reduction method, starch as the capping agent, a synthesis temperature of 50°C and 
after a week of aging, the nanoparticles were mostly spherical in shape and all of a similar size 
range. 
The silver nanoparticles produced by chemical reduction with starch as the capping agent and 
synthesised at 100°C are shown in Figure 4.24. At a concentration of 5mg/ml the average 
particle size was 181 and 287nm with standard deviations of 93 and 287nm respectively. At a 
starch concentration of 10mg/ml the average size became 86 and 73nm with standard 
deviations of 53 and 54nm. When the starch concentration was increased to 50mg/ml the 
average particle sizes became 216 and 154nm with standard deviations of 140 and 163nm. At 
a starch concentration of 5 and 10mg/ml the shape majority was spherical (72-94%). At 
50mg/ml however the shape majority was irregular particles (87 and 72%) but the remaining 
percentage was mostly made up of spherical particles. For the synthesis of silver nanoparticles 
produced via chemical reduction, at 100°C, with starch as the capping agent and after a week 
of aging at low starch concentrations, the particles were spherical in shape. The smallest 
particle shapes were generated in concentrations of 10mg/ml and the highest rates of 
irregularity were at 50mg/ml.   
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Figure 4.22. Analysis of the synthesis at 20°C SEM images collected for duplicate samples. The histograms show 
the particle sizes morphology and size distribution of a single sample (n100-150). From these measurements 
the average size and standard deviation (SD) were determined and presented. Of the measured particles, shape 
was determined and presented as a percentage. 
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Figure 4.23. Analysis of the synthesis at 50°C SEM images collected for duplicate samples. The histograms show 
the particle sizes morphology and size distribution of a single sample (n100-150). From these measurements 
the average size and standard deviation (SD) were determined and presented. Of the measured particles, shape 
was determined and presented as a percentage. 
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Figure 4.24. Analysis of the synthesis at 100°C SEM images collected for duplicate samples. The histograms 
show the particle sizes morphology and size distribution of a single sample (n100-150). From these 
measurements the average size and standard deviation (SD) were determined and presented. Of the measured 
particles, shape was determined and presented as a percentage. ‘*’ indicated were average rod length was also 
determined. Note that at 50mg/ml the x-axis of the graph is greater.  
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4.3.2. PVP as the capping agent  
From the synthesis of silver nanoparticles using the chemical reduction method with PVP as 
the capping agent after a week of aging the UV-vis results are shown in Figure 4.25 and Table 
4.6. Figure 4.25 contains the UV-vis data graphs of a single representative duplicate, while 
Table 4.6 presents the data from both replicates. At the synthesis temperature of 20°C the 
peak wavelength produced by the sample becomes larger with increased PVP concentration. 
For 20°C at 5mg/ml of PVP the peaks are at 407 and 406nm while at 10mg/ml the peak 
wavelength is at 409 and 410nm.  At 50°C synthesis temperature peaks were only observed 
at a 5mg/ml PVP concentration to which the peaks were 406.5 and 405.5nm, this result being 
similar to that of 5mg/ml at 20°C. The PWHM shown in Table 4.6 increased with increasing 
PVP concentration for the 20°C synthesis temperature, ranging from 68 and 66nm at 5mg/ml 
to 69 and 74nm at 10mg/ml. At the 50°C synthesis temperature there were peaks only at the 
5mg/ml PVP concentration and the PWHM were 77 and 64nm. For the synthesis of silver 
nanoparticles via chemical reduction with PVP as the capping agent after a week of aging, the 
synthesis temperature of 20°C, showed a trend of increased peak wavelength and peak width 
with increasing PVP concentration. 
  
Figure 4.25. UV-vis data extracted from the silver nanoparticles produced via chemical reduction method with PVP as the 
capping agent after a one-week aging period. Samples of varying temperature (20, 50 and 100°C) and PVP concentration (5 
and 10 mg/ml) were tested. Tests were performed on duplicate samples, however only one represented duplicate has been 
provided, see Appendix 9 for full result. 
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Table 4.6. Silver nanoparticle peak wavelengths and peak width at half maximum (PWHM) obtained from the 
UV-vis data provided in Figure 4.1.1.1. 
Synthesis 
temperature 
Capping agent 
concentration 
Duplicate Peak wavelength (nm) PWHM (nm) 
20 
5mg/ml 
1 407 68 
2 406 66 
10mg/ml 
1 409 69 
2 410 74 
50 
5mg/ml 
1 406.5 77 
2 405.5 64 
10mg/ml 
1 No peak NA 
2 No peak NA 
100 
5mg/ml 
1 No peak NA 
2 No peak NA 
10mg/ml 
1 No peak NA 
2 No peak NA 
 
 
The aged silver nanoparticles produced via chemical reduction with PVP as the capping agent 
were then imaged using SEM for duplicate samples. A single represented image was selected 
from each synthesis condition and presented in Figure 4.26.  The Images presented in Figure 
4.26 show a sample of rod shape particles except at 5mg/ml at 100°C. Further, rod size is 
largest at low temperatures and low PVP concentration, the largest at 20°C at 5mg/ml. Size 
of the rods then progressively became smaller as temperature and concentration increased. 
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Figure 4.26. Silver nanoparticles with varying temperatures and starch concentrations after a 7-day aging 
period. All photos at 50,000x magnification at 5kV. Scale bar at 200nm (bottom right corner). Additional 
images in Appendix 10. 
 
The results of the SEM were further analysed to produce Figures 4.27 through 4.29. Figure 
4.27 represents the data from the images taken of the silver nanoparticles produced via 
chemical reduction with PVP as the capping agent at 20°C after 1 week of aging. The 
averages produced by the synthesis, at concentrations of 5mg/ml of PVP, produced much 
larger average particles sizes of 152 and 131nm than that of the 10mg/ml PVP synthesis of 
47 and 69nm. However, the standard deviation for the nanoparticles synthesised with 
5mg/ml were also much larger at 72 and 68nm for 5mg/ml and 18 and 29nm for 10mg/ml. 
The sample produced a majority of rod shapes with percentages between 54% and 87% with 
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the remaining percentage mostly being made up with spherical particles at 13 to 39%. The 
rod length was also measured, and the averages are given in Figure 4.27. For 5mg/ml the 
average rod length was much larger than at 10mg/ml being 1279 and 1105nm for 5mg/ml 
and 280 and 518nm for 10mg/ml. For a 7-day aged sample of silver nanoparticles 
synthesised via chemical reduction with PVP as the capping agent, and at a temperature of 
20°C, particle size and standard deviation were larger at lower PVP concentration and all 
samples showed a rod-shape majority (54-87%). 
 
Figure 4.27. Analysis of the synthesis at 20°C SEM images collected for duplicate samples. The histograms show 
the particle sizes morphology and size distribution of a single sample (n100-150). From these measurements 
the average size and standard deviation (SD) were determined and presented. Of the measured particles, shape 
was determined and presented as a percentage. ‘*’ indicated were average rod length was also determined. 
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Figure 4.28. Analysis of the synthesis at 50°C SEM images collected for duplicate samples. The histograms show 
the particle sizes morphology and size distribution of a single sample (n100-150). From these measurements 
the average size and standard deviation (SD) were determined and presented. Of the measured particles, shape 
was determined and presented as a percentage. ‘*’ indicated where average rod length was also determined. 
 
The silver nanoparticles that were synthesised using the chemical reduction methods, PVP 
and a temperature of 50°C are shown in Figure 4.28. All samples were similar in average 
particle size (78, 86 and 100nm) except in the 5mg/ml duplicate 1 which produced an average 
smaller size of 45nm. The standard deviation was also smaller for the 5mg/ml duplicate 1 
sample at 15nm while the others had standard deviations of 30, 34 and 49nm. The shape 
majority was yet again rod-shaped (66 to 88%). The synthesis at 50°C produced the largest 
average rod length of 230, 780, 466 and 468nm. The aged sample produced via chemical 
reduction with PVP as the capping agent and at a synthesis temperature of 50°C produced 
mostly rod-shaped particles.   
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Figure 4.29. Analysis of the synthesis at 100°C SEM images collected for duplicate samples. The histograms 
show the particle sizes morphology and size distribution of a single sample (n100-150). From these 
measurements the average size and standard deviation (SD) were determined and presented. Of the measured 
particles, shape was determined and presented as a percentage. ‘*’ indicated where average rod length was 
also determined. 
 
The silver nanoparticles synthesised using the chemical reduction method at 100°C with 
starch as the capping agent after a one-week aging period are shown in Figure 4.29. The silver 
nanoparticles width for the two PVP concentrations were similar, 86 and 107nm for 5mg/ml 
and 78 and 95nm for 10mg/ml. All the sample showed a standard deviation between 27 and 
36nm. However, the two PVP concentrations did differ in their particle shape percentages 
with 5mg/ml producing 93% and 94% spherical shapes while 10mg/ml produced 69% and 66% 
rod shaped particles. These rod-shape particles had an average length of 324 and 342nm. For 
the synthesis of silver nanoparticles using the chemical reduction method at 100°C with PVP 
as the capping agent, after a week of aging, the particles synthesis at 5mg/ml PVP were 
spherical in shape while at higher concentrations of 10mg/ml PVP particles were rod-shaped 
and larger in length. 
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4.4. Heat reduction method, 1 week aged 
The silver nanoparticles produced by heat reduction were also aged for 1 week. These 
samples were analysed using the UV-vis described in Figure 4.30 and Table 4.7. Figure 4.30 
shows the output of a single duplicate from the two synthesis conditions and Table 4.7 
provides data from both duplicates. The peak wavelength produced by the sample 
synthesised at 170°C are much larger than those at 150°C. The synthesis at 170°C also 
produced the largest PWHM of 287 and 257nm while the synthesis at 150°C produced peak 
widths of 287 and 257nm. For the synthesis of silver nanoparticles via the heat reduction 
method the higher synthesis temperature produced a greater peak wavelength and peak 
width. 
 
 
Figure 4.30. UV-vis data extracted from the silver nanoparticles produced via heat reduction method after a 7-
day aging period. Samples of varying temperature (150 and 170°C) were tested. Tests were performed on 
duplicate samples however only one represented duplicate has been provided, see Appendix 11 for full result 
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Table 4.7. Silver nanoparticle peak wavelengths and peak width at half maximum (PWHM) obtained from the 
UV-vis data provided in Figure 4.30. 
Synthesis temperature Replicate 
Peak wavelength 
(nm) 
PWHM 
(nm) 
150°C   
1 417 114 
2 414.5 96 
170°C   
1 502 287 
2 442.4 257 
 
 
Figure 4.31. Silver nanoparticles with heat reduction and varying temperatures after 7-days of aging. All photos 
at 100,000x magnification at 5kV. Scale bar at 200nm (bottom right corner). Additional images in Appendix 12. 
 
For the silver nanoparticles produced via heat reduction methods, the SEM images taken, and 
the analysis of these images are shown in Figure 4.31 and 4.32. From Figure 4.31 it is easily 
observed that at 150°C the sample is made up of small spheres and irregular shapes. However, 
at 170°C the sample is comprised of rods, spheres and irregular shapes of a considerably 
larger scale. The samples synthesised at 150°C produced particles of an average size of 45 and 
46nm with a standard deviation of 14 and 17nm respectively. When synthesised at 170°C the 
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average particle size was 256 and 308nm with standard deviations of 242 and 261nm. Shape 
types were different at treatments at 150°C, producing a majority of spherical particles (68 
and 63%) with the remaining particles irregular in shape. At a synthesis of 170°C the sample 
was made up of 47 and 58% irregular in shape, 31 and 28% spherical and 21 and 23% rod 
shaped. The rods synthesised at 170°C showed very large rod lengths averaging 13’315 and 
9’996nm. For the synthesis of silver nanoparticles via heat reduction after a week of aging, 
150°C synthesis temperatures produced a sample majority of small spheres while 
temperatures of 170°C had nanoparticles much larger, irregular and rod shaped. 
 
Figure 4.32. Analysis of the synthesis at 150 and 170°C via heat reduction method SEM images collected for 
duplicate samples. The histogram shows the particle sizes and size distribution of a single sample (n>100) using 
ImageJ. From these measurements the average size, standard deviation (SD) and mode particles size were 
determined and presented. Of the measured particles shape was determined and presented as a percentage. 
‘*’ indicated where average rod length was also determined. 
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4.5. Antimicrobial properties of silver nanoparticle at time zero 
All silver nanoparticles produced were characterised using UV-vis and SEM and then tested 
for their antimicrobial properties. The antimicrobial properties of each silver nanoparticle 
sample have been determined by performing MICs and MBC/MFCs. 
 
4.5.1. Chemically reduced nanoparticles  
4.5.1.1. Starch as the capping agent 
The silver nanoparticles produced via the chemical reduction method with starch as the 
capping agent produced antimicrobial effects which varied over the four microbes (Table 4.8).  
P. aeruginosa was the most effected by the silver nanoparticles, inhibiting growth by 90% at 
a concentration of 3-6µg/ml. E. coli was the second most effected, with growth inhibited at 
6-12µg/ml. S. aureus and C. albicans were the least effected, with S. aureus requiring a 
concentration of 6µg/ml to >12µg/ml to inhibit growth and C. albicans requiring ≥12µg/ml. 
Dissolved silver nitrate or silver ions required concentrations of >12µg/ml to inhibit bacterial 
cell growth. Starch at a concentration of 50µg/ml was also tested against the four microbes 
as a control to determine any antimicrobial effect, however no inhibitory effect was observed. 
The silver nanoparticles produced via chemical reduction with starch as the capping agent did 
not show varied antimicrobial properties within different synthesis temperatures and starch 
concentrations. The silver nanoparticles synthesised using starch were most effective against 
P. aeruginosa. 
The microbes were then tested to see if they had been killed or simply inhibited. The results 
of this test are shown in Table 4.9. The silver nanoparticles synthesised at 20°C showed 
bactericidal properties against P. aeruginosa and E. coli (only at low starch concentration), 
killing bacteria at a 12µg/ml concentration. The silver nanoparticles were also able to kill E. 
coli at a concentration of 6µg/ml when the particles were synthesised at 20°C and at 5mg/ml 
starch concentration. 
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Table 4.8. Minimum inhibitory concentration of silver nanoparticles synthesised via chemical reduction method 
with starch as the capping agent. Particles were synthesised at three temperatures (20, 50 and 100°C) and 
three starch concentrations (5, 10 and 50mg/ml). Each sample was tested in duplicates against the four 
microbes P. aeruginosa, E. coli, S. aureus and C. albicans. The MIC was identified by a growth inhibition of 90% 
or greater (n=4).  
Temperature Starch 
concentration 
(mg/ml) 
Minimum Inhibitory Concentration (µg/ml) 
P. aeruginosa E. coli S. aureus C. albicans 
20°C 5 3, 3 >12, 6 >12, >12 >12, >12 
 10 3,6 >12, 6 >12, >12 >12, >12 
 50 3,3 6,6 >12, >12 >12, >12 
50°C 5 3, 3 6, 6 12, 12 >12, >12 
 10 3, 3 6, 6 6, 6 12, 12 
 50 1.5, 3 3, 6 6, 6 12, 12 
100°C 5 3, 3 6, 12 12, 12 >12, >12 
 10 3, 3 6, 6 3, 6 12, 12 
 50 1.5, 6 6, 6 6, 12 12, 12 
AgNO₃ (Ag⁺)  >12, >12 >12, >12 >12, >12 >12, >12 
 
 
Table 4.9. Minimum concentration of silver nanoparticles required to kill the microbial organism. Silver 
nanoparticles were synthesised via chemical reduction with starch as the capping agent. Synthesis 
temperatures varied from 20, 50 or 100°C and starch concentration were either 5, 10 or 50mg/ml. Each sample 
was tested in duplicates against the four microbes P. aeruginosa, E. coli, S. aureus and C. albicans. MBC/MFC 
was identified by no bacterial growth (n=4). 
Temperature Starch 
concentration 
(mg/ml) 
Minimum Bactericidal/Fungicidal Concentration (µg/ml) 
P. aeruginosa E. coli S. aureus C. albicans 
20°C 5 12 6 >12 >12 
 10 12 12 >12 >12 
 50 12 >12 >12 >12 
50°C 5 12 >12 >12 >12 
 10 12 >12 >12 >12 
 50 >12 >12 >12 >12 
100°C 5 >12 >12 >12 >12 
 10 >12 >12 >12 >12 
 50 >12 >12 >12 12 
AgNO₃ (Ag⁺)  >12 >12 >12 >12 
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4.5.1.2. PVP as the capping agent 
The silver nanoparticles produced via chemical reduction with PVP as the capping agent 
showed variation in antimicrobial properties across all microbes and slight variation across 
synthesis variables (Table 4.10). Again P. aeruginosa was the most susceptible to the silver 
nanoparticles. However, the silver nanoparticles appeared to be most effective when 
synthesised at 20 and 50°C, requiring concentrations of 1.5-6µg/ml. For silver nanoparticles 
that were synthesised at 100°C, concentrations of ≥12µg/ml were required to inhibit growth. 
E. coli and S. aureus showed this same pattern of reduced antimicrobial susceptibility when 
the nanoparticles were synthesised at 100°C. At 20 and 50°C E. coli was inhibited by 90% at a 
silver nanoparticle concentration of 3-6µg/ml whereas at 100°C concentrations >12µg/ml 
were required. To inhibit the growth of S. aureus a concentration of 3-12µg/ml and synthesis 
temperature of 20 or 50°C was required and at 100°C concentrations of >12µg/ml were 
needed. C. albicans was again the least effected by the silver nanoparticles requiring 
concentrations >12µg/ml for all synthetic temperatures and PVP concentrations. Again, silver 
nitrate was tested at the same concentrations and no microbial inhibition was observed. The 
compound PVP was also tested for antimicrobial properties at the concentration 10mg/ml 
and showed no inhibitory effect on any of the four microbes.  
The results of the MBC and MFC are shown in Table 4.11. Only silver nanoparticles which were 
synthesised at 20°C, with 5mg/ml of PVP, were bactericidal however, only against P. 
aeruginosa and E. coli. Limited difference in the antimicrobial properties was observed 
between the nanoparticles synthesised with different PVP concentrations. For the synthesis 
of silver nanoparticles via chemical reduction with PVP as the capping agent, P. aeruginosa 
was the most susceptible to the silver nanoparticles’ bactericidal qualities. Further, the 
nanoparticles synthesised at 20 and 50°C were slightly more effective at inhibiting microbial 
cell growth. 
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Table 4.10. Minimum inhibitory concentration of silver nanoparticles synthesised via chemical reduction 
method with PVP as the capping agent. Particles were synthesised at three temperatures (20, 50 and 100°C) 
and two PVP concentrations (5 and 10mg/ml). Each sample was tested in duplicate against the four microbes 
P. aeruginosa, E. coli, S. aureus and C. albicans. The MIC was identified as the lowest concentration which 
inhibited growth by 90% or greater (n=4). 
Temperature PVP 
concentration 
(mg/ml) 
Minimum Inhibitory Concentration (µg/ml) 
P. aeruginosa E. coli S. aureus C. albicans 
20°C 5 6, 1.5 6, 3 12, 6 >12, >12 
 10 1.5, 3 6, 3 6, 3 >12, >12 
50°C 5 3, 1.5 3, 3 6, 6 >12, >12 
 10 6, 6 6, 6 6, 12 >12, >12 
100°C 5 12, 12 >12, >12 >12, >12 >12, >12 
 10 >12, >12 >12, >12 >12, >12 >12, >12 
AgNO₃ (Ag⁺)  >12, >12 >12, >12 >12, >12 >12, >12 
 
 
Table 4.11. Minimum concentration of silver nanoparticles required to kill the microbial organism. Silver 
nanoparticles were synthesised via chemical reduction with PVP as the capping agent. Synthesis temperatures 
varied from 20, 50 or 100°C and PVP concentration were either 5 or 10mg/ml. Each sample was tested in 
duplicate against the four microbes P. aeruginosa, E. coli, S. aureus and C. albicans. MBC/MFC was identified as 
the lowest concentration causing no bacterial growth (n=4). 
Temperature PVP 
concentration 
(mg/ml) 
Minimum Bactericidal/Fungicidal Concentration (µg/ml) 
P. 
aeruginosa 
E. coli S. aureus C. albicans 
20°C 5 12 12 >12 >12 
 10 >12 >12 >12 >12 
50°C 5 >12 >12 >12 >12 
 10 >12 >12 >12 >12 
100°C 5 12 >12 >12 >12 
 10 >12 >12 >12 >12 
AgNO₃ (Ag⁺)  >12 >12 >12 >12 
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4.5.2. Heat reduced nanoparticles  
The silver nanoparticles that were synthesised using the heat reduction method at either 150 
or 170°C were also tested for their antimicrobial properties (Table 4.12). The silver 
nanoparticles produced via this method at 150°C were similar across all microbes with only a 
small two-fold concentration increase required for C. albicans. MIC against P. aeruginosa, E. 
coli and S. aureus was 3 µg/ml compared to an MIC of 6 µg/ml against C. albicans. When the 
particles were synthesised at 170°C, the MIC for P. aeruginosa was 1.5µg/ml while the MIC 
for E. coli was 1.5-3µg/ml, 1.5-3µg/ml against S. aureus and 6 µg/ml against C. albicans.  
A solution of silver nitrate was tested at the relevant concentration (12µg/ml) and no growth 
inhibition was observed. As a control Na₂S, EG and PVP were also tested for any antimicrobial 
properties, to confirm that the antimicrobial effects were solely due to the silver 
nanoparticles. No antimicrobial effect was observed for any of the reagents at the 
concentrations used for the synthesis, the MICs for Na₂S, EG and PVP were >50µg/ml, >50% 
and >14mg/ml respectively (Appendix 13). Silver nanoparticles produced via heat reduction 
synthesis exhibited strong antimicrobial properties against the four tested microorganisms.  
 
Table 4.12. Minimum inhibitory concentration of silver nanoparticles synthesised via the heat reduction 
method. Particles were synthesised at either 150 or 170°C. Each sample was tested in duplicate against the four 
microbes P. aeruginosa, E. coli, S. aureus and C. albicans. The MIC was identified as the lowest concentration 
which inhibited growth by 90% or greater (n=4). 
Temperature Minimum Inhibitory Concentration (µg/ml) 
P. aeruginosa E. coli S. aureus C. albicans 
150°C 3, 3 3, 3 3, 3 6, 6 
170°C 1.5, 1.5 1.5, 1.5 3, 3 6, 6 
AgNO₃ (Ag⁺) >12, >12 >12, >12 >12, >12 >12, >12 
 
 
Table 4.13. Minimum concentration of silver nanoparticles required to kill the microbial organism. Silver 
nanoparticles were synthesised via heat reduction at either a 150°C or 170°C. Each sample was tested in 
duplicate against the four microbes P. aeruginosa, E. coli, S. aureus and C. albicans. MBC/MFC was identified as 
the lowest concentration resulting in no bacterial growth (n=4). 
Temperature Minimum Bactericidal/Fungicidal Concentration (µg/ml) 
P. aeruginosa E. coli S. aureus C. albicans 
150°C 6 3 >12 12 
170°C 3 3 >12 12 
AgNO₃ (Ag⁺) >12 >12 >12 >12 
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The results presented in Table 4.13 show some bactericidal and even fungicidal activity. Silver 
nanoparticles synthesised at 150°C killed P. aeruginosa, E. coli and C. albicans at a 
concentration of 6, 3 and 12µg/ml respectively. At a synthesis temperature of 170°C silver 
nanoparticles killed P. aeruginosa and E. coli at concentration of 3µg/ml and C. albicans at 
12µg/ml. S. aureus was inhibited but not killed by particles synthesised at either temperature. 
The silver nanoparticles synthesised using the heat reduction method showed both 
bactericidal and fungicidal properties with a particularly strong killing effect against E. coli. 
 
4.6. Antimicrobial activity of aged silver nanoparticles  
After the synthesised silver nanoparticles had been characterised, tested for antimicrobial 
properties, aged for 7 days and characterised again, the samples were again tested for 
antimicrobial activity. MICs were identified as the lowest concentration causing a 90% 
reduction in microbial growth when compared to the positive control. Particles produced by 
both the chemical reduction and the heat reduction methods were tested again after a 7-day 
aging period for their antimicrobial properties. 
 
4.6.1. Chemical reduction method  
 
4.6.1.1. Starch as the capping agent 
Silver nanoparticles produced using the chemical reduction method with starch as the 
capping agent showed limited antimicrobial properties (Table 4.14). After a week of aging the 
silver nanoparticles produced via the chemical reduction method with starch as the capping 
agent showed a limited antimicrobial effect, except against P. aeruginosa where the 
nanoparticles inhibited at low starch concentration and low synthesis temperatures.  
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Table 4.14. Minimum inhibitory concentration of silver nanoparticles synthesised via chemical reduction 
method with starch as the capping agent after one week of aging. Particles were synthesised at three 
temperatures (20, 50 and 100°C) and three starch concentrations (5, 10 and 50mg/ml). Each sample was tested 
in duplicate against the four microbes P. aeruginosa, E. coli, S. aureus and C. albicans. The MIC was identified 
as the lowest concentration causing growth inhibition of 90% or greater (n=4).  
Temperature Starch 
concentration 
(mg/ml) 
Minimum Inhibitory Concentration (µg/ml) 
P. aeruginosa E. coli S. aureus C. albicans 
20°C 5 3, 3 >12, >12 12, 12 >12, >12 
 10 3, 3 >12, >12 12, 12 >12, >12 
 50 6, 6 >12, >12 >12, >12 12, >12 
50°C 5 6, 6 >12, >12 12, >12 >12, >12 
 10 6, 6 >12, >12 12, 12 >12, >12 
 50 12, 12 >12, >12 >12, >12 12, >12 
100°C 5 6, 6 12, >12 6, 6 >12, 12 
 10 3, 6 >12, >12 6, 6 >12, >12 
 50 >12, >12 >12, >12 >12, >12 12, 12 
AgNO₃ (Ag⁺)  >12, >12 >12, >12 >12, >12 >12, >12 
 
 
 
4.6.1.2. PVP as the capping agent 
Table 4.15 shows the MIC results of the silver nanoparticles synthesised using the chemical 
reduction method with PVP as the capping agent after one week of aging. P. aeruginosa was 
the most susceptible to the silver nanoparticles however only at low PVP concentrations and 
high temperatures. E. coli when treated with the one-week aged and PVP samples was 
unaffected by the silver nanoparticles resulting in an MIC of >12µg/ml. S. aureus showed 
susceptibility to aged silver nanoparticles but only at low temperatures (20°C) and low PVP 
concentrations (5mg/ml). C. albicans required a concentration of greater than >12µg/ml to 
inhibit microbial growth. The silver nanoparticles synthesised using the chemical reduction 
method with PVP as the capping agent and aged for a week showed limited microbial 
inhibition. 
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Table 4.15. Minimum inhibitory concentration of silver nanoparticles synthesised via chemical reduction 
method with PVP as the capping agent after one week of aging. Particles were synthesised at three 
temperatures (20, 50 and 100°C) and two PVP concentrations (5 and 10mg/ml). Each sample was tested in 
duplicate against the four microbes P. aeruginosa, E. coli, S. aureus and C. albicans. The MIC was identified as 
the lowest concentration resulting in growth inhibition of 90% or greater (n=4). 
Temperature PVP 
concentration 
(mg/ml) 
Minimum Inhibitory Concentration (µg/ml) 
P. aeruginosa E. coli S. aureus C. albicans 
20°C 5 3, 3 >12, >12 6, 12 >12, >12 
 10 >12, >12 >12, >12 >12, >12 >12, >12 
50°C 5 6, 6 >12, >12 12, 12 >12, >12 
 10 12, 12 >12, >12 >12, >12 >12, >12 
100°C 5 3, 3 >12, >12 >12, >12 >12, >12 
 10 6, 6 >12, >12 >12, >12 >12, >12 
AgNO₃ (Ag⁺)  >12 >12 >12 >12 
 
 
4.6.2. Heat reduction method  
The antimicrobial activity of the silver nanoparticles synthesised using the heat reduction 
method at 150°C and 170°C after being aged for one week are shown in Table 4.16. For P. 
aeruginosa and E. coli, silver nanoparticle concentrations of 3µg/ml were required to inhibit 
bacterial growth for both the 150°C and 170°C synthesis temperatures. For S. aureus and C. 
albicans the required inhibitory concentration after a week of aging were 6µg/ml to >12µg/ml 
and 12µg/ml respectively. 
Table 4.16. Minimum inhibitory concentration of silver nanoparticles synthesised via the heat reduction method 
after one week of aging. Particles were synthesised at either 150 or 170°C. Each sample was tested in duplicate 
against the four microbes P. aeruginosa, E. coli, S. aureus and C. albicans. The MIC was identified as the lowest 
concentration causing growth inhibition of 90% or greater (n=4). 
Temperature 
 
Minimum Inhibitory Concentration (µg/ml) 
P. aeruginosa E. coli S. aureus C. albicans 
150°C 3, 3 3, 3 6, >12 12, 12 
170°C 3, 3 3, 3 6, >12 12, 12 
AgNO₃ (Ag⁺) >12, >12 >12, >12 >12, >12 >12, >12 
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Chapter 5. Discussion  
The use of silver nanoparticles in day to day life is becoming more and more common. Silver 
nanoparticles are used for biosensing, surface enhanced Raman scattering, electronics and 
even as an antimicrobial agent in products such as detergents, textiles, cosmetics and medical 
equipment(5). However, there is a limited understanding about silver nanoparticles and how 
time and morphology may be used to enhance or constrain their performance. This is 
increasingly important for issues such as environmental persistence (122). The aims of this 
study were to investigate and compare different synthesis methods, appraise their 
antimicrobial properties and determine the effect(s) of aging of silver nanoparticles. 
Investigating silver nanoparticle characteristics allows for the potential to customize silver 
nanoparticles for their end purpose. 
 
 
5.1. Reproducibility of synthesis methods 
The production of silver particles of the nanoscale can be difficult to control to achieve high 
reproducibility.  This is due to nanoparticle morphology being easily affected by external 
variables. Developing the perfect conditions for nanoparticle synthesis can take a lot of 
repetition and trial and error. This project has contributed by highlighting some of the 
conditions that must be controlled. 
Controlling the reaction kinetics in the synthesis of silver nanoparticles is crucial in achieving 
a uniform product(84). It was found during this study that a stirring speed that was too fast, or 
too slow, caused the sample to aggregate. Research done by Skrabalak et al. (87) 
recommended a stirring speed of 260-350rpm. In this study a similar speed of 240rpm was 
used. Further, the speed at which the chemicals, particularly silver nitrate, were added 
affected the reaction kinetics. Again, a speed that is too fast, or too slow, can cause the sample 
to aggregate. In many reported experiments, automated pipets were used to accurately 
control the delivering time of a chemical to the reaction(94). In this synthesis an addition speed 
of 1.5ml/min was used, similar to that of Xu et al. (61). Furthermore, it was found that the vial 
and magnetic stirrer dimensions affected the synthesis conditions and the final product, as 
they altered mixing rates. This study followed the glassware protocols of Skrabalak et al. (87).  
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Many research papers have highlighted the importance of minimal light exposure in the 
synthesis of silver nanoparticles (92). Silver nitrate is known to be affected by light and it is a 
common practice when dissolved in water to wrap it in foil to prevent this light damage(87). 
However, in the synthesis of silver nanoparticles it was found that even more care was needed 
to limit light exposure. Our experiments confirmed this earlier research (92), finding that 
natural sunlight had a large affect, causing samples to aggregate during synthesis. However 
artificial lighting only affected the synthesis using the heat reduction method 
Silver nitrate forms a coat on glass and this coating, if not removed, interferes with the 
synthesis of the silver nanoparticles(48). For the synthesis via chemical reduction, it was found 
that using new vials, and washing the magnetic stirrers and spatulas with acetone under 
sonication, was able to remove enough silver coating to prevent sample aggregation and 
prevent interference in the resulting product. A similar method of cleaning was also used by 
Mulfinger et al. (88). For the silver nanoparticle synthesis performed by heat reduction a more 
intensive cleaning method was required. Research such as that by Skrabalak et al. (87) 
recommended the use of a piranha or aqua regia solution for cleaning. To prevent handling 
these toxic solutions, for this study new glass wear, magnetic stirrers and disposable spatulas 
were used.  
Only after all of the above variables were controlled was it possible to obtain reproducible 
results and to start comparing the effects of synthesis methods, temperature, capping agents 
and reaction concentrations on nanoparticle characteristics.  
  
5.2. Characterisation of silver nanoparticles 
The two methods and three capping agents chosen for this study are commonly used in the 
synthesis of silver nanoparticles. However, studies which experimentally compare these 
methods are limited. As explained in Section 5.2, many external variables affect the 
reproducibility of silver nanoparticle synthesis (60, 102, 106, 123). This study controlled the 
synthesis environment and compared the produced nanoparticles of two synthesis 
methodologies; chemical and heat reduction and three capping agents; starch, PVP, citrate. 
For chemical reduction, three capping agents were selected; these were starch, PVP and 
citrate. In order to best compare the three capping agents a consistent method was used. 
Darcy Burns-Dunn, 18018282                                                                                               
76 
 
Starch was chosen as a capping agent due to it being organic and environmentally friendly (47, 
105, 106), thus avoiding the use of harsh and toxic chemicals. Additionally, the binding 
interaction between starch and the silver nanoparticles are weak and can be reversible at high 
temperatures(50). Further, soluble starch is readily available and inexpensive. Starch was able 
to quickly and consistently produce silver nanoparticles (Section 4.1.1). The eco-friendly 
approaches are better suited to large scale commercial production and for biomedical and 
pharmaceutical applications than their more harmfully produced silver nanoparticle 
counterparts (106).  
PVP is a commonly and regularly used polymer for capping and stabilising nanoparticles(93, 95), 
due to its ability to promote the synthesis of a wide variety of high-quality particle 
morphologies (57). PVP is considered a safe and low hazard chemical (124). PVP is however more 
expensive and has more environmental impact than starch. However, it was selected for 
testing as it is well known for its ability to produce polydisperse silver nanoparticles (13, 44, 59, 
81, 88, 93). 
Citrate, like PVP, was chosen as it is a commonly used capping agent in the production of silver 
nanoparticles(6, 48). Unlike PVP however, citrate is considered toxic(106). This toxicity, however, 
can be overlooked if the silver nanoparticles produced are highly uniform, have antimicrobial 
properties and are stable. However, for the chemical synthesis of silver nanoparticles using 
citrate as the capping agent the results showed a majority of aggregated particles. The colours 
of the sample over the 5 citrate concentrations were a dull grey colour which correlates with 
an aggregated sample, however the sample at 50mg/ml showed a yellowish tinge (Figure 
4.13). This sample presented UV-vis data with a small peak in one replicate and no peak in 
the other duplicate (Section 4.1.3). Further, investigation using SEM (Figure 4.15) indicated 
the sample had high particle aggregation. Some syntheses such as those reported by Haber 
et al. (121) added hydrogen peroxide and ascorbic acid in order to produce well-defined 
polydisperse silver nanoparticles. Such an addition may have led to the production of a silver 
nanoparticles suspension which was not aggregated (121). However, in this project the 
chemical reduction method with citrate as the capping agent did not produced silver 
nanoparticles. 
The heat reduction method, also known as the polyol method, was chosen for its reported 
ability to produce a more uniform product of very small nanoparticles (10nm) (92, 94, 102). It was 
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further chosen for its ability to produce nanorods or nanowires at elevated temperatures 
(>160°C) (89). This method uses high temperature to reduce the silver nitrate and PVP as the 
capping agent resulting in a highly uniform product (Table 2.2).  
The sizes and size deviations varied dramatically across the synthesis methods (Figures 4.4-6, 
4.10-12 and 4.19). The size of the nanoparticles is important as it alters the properties of the 
silver nanoparticles by changing the total surface area (48). The heat reduction method at 
150°C produced the smallest particles and standard deviations (SD) (8±3-5nm). The chemical 
reduction method, with starch as the capping agent, produced the largest particles (235-
354±208-381nm). Nanoparticle size not only varied between methods but also within 
methods when synthesis temperatures and capping agent concentrations were altered.  
 
For the synthesis of silver nanoparticles by the chemical reduction method with starch as the 
capping agent the smallest particles were produced at a synthesis temperature of 20°C and 
50°C with the largest at synthesis temperatures of 100°C. The standard size deviations all 
increased with increasing particle size. The large standard deviations identified at the 
synthesis temperature of 100°C are likely due to starch’s susceptibility to elevated 
temperatures (106). Sun et al. (94) highlighted the importance of reaction temperature on final 
product morphology. The starch capped silver nanoparticles sensitivity to heat is not 
inherently a negative attribute and if understood and controlled could be used to inactivate 
the silver nanoparticles when they have performed their purpose (106). This form of silver 
nanoparticles therefore provides a greener alternative in silver nanoparticle research. For the 
synthesis of silver nanoparticles with chemical reduction and starch as the capping agent the 
smaller particle sizes were identified at synthesis temperatures of 20 and 50°C and larger sizes 
in treatments at 100°C. 
For the chemical reduction synthesis with PVP as the capping agent the nanoparticles showed 
a similar average size across all three synthesis temperatures and PVP concentrations. The 
synthesis using PVP also produced similar SD across all concentrations and temperatures. This 
suggests that PVP concentration and synthesis temperature are having little to no effect on 
the silver nanoparticle size. For the synthesis performed at 20°C the average nanoparticles 
size was 41 ±20.5nm which is very similar to the 37.6 ±21nm particles reported by Kubo et al. 
(44)  who used a similar synthesis method. 
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For synthesis using heat reduction, the two synthesis temperatures tested showed markedly 
different results. At 150°C the particles produced were very small at 8nm with a size variation 
of 4nm (Table 5.1). Skrabalak et al. (87) and Gorka et al. (119) used a similar method and 
produced an average particle size of 45nm and 36.6nm respectively. When the synthesis 
temperature was increased to 170°C the average nanoparticle width increased to 64 and 
71nm with an increase in standard deviation. Both Gorka et al. (119) and Wiley et al. (123) also 
found an elevated temperature produced silver nanoparticles with an increased average size, 
which aligns with the findings in this study. 
All of the three synthesis procedures showed different size ranges and size SD. The silver 
nanoparticle synthesis using chemical reduction and using PVP as a capping agent produced 
a much more uniform product than was produced using starch as the capping agent (Table 
5.1). However, it was the heat reduction method which produced the most uniform product, 
producing the smallest average size and SD. A low SD is important as it means the sample is 
highly uniform and predicable in its effect and outcomes. 
 
Table 5.1 Summary of nanoparticles of different size, shape and shape variations. Results are averages of all 
results within their synthesis condition. 
Method 
Capping 
agent 
Synthesis condition Size Shape 
Chemical 
reduction 
Starch 20°C 134 ±68.5nm Cubic (76.6%) 
  50°C, 5mg/ml 32.5 ±31nm Spherical (70.5%) 
 PVP 20°C 41 ±20.5nm Spherical (94.5%) 
Heat 
reduction 
PVP 150°C 8 ±4nm Spherical (95%) 
  170°C 67.5 ±32nm 
Spherical (56.5%) 
Rod (40%) 
 
Not only did the size and SD vary between different synthesis methods but the silver 
nanoparticle shape also varied. Nanoparticles come in a wide variety of shapes such as 
spheres, cubes, rods, tetrahedrons and octahedrons (60). The shape and their corresponding 
shape percentage for both the chemical reduction (starch and PVP capped) and heat 
reduction synthesis methods were compared (Table 5.1).  
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Chemical reduction methods using starch as the capping agent, at synthesis temperatures of 
20°C, showed a majority production of cubic shaped particles (Figure 4.4). However, when 
synthesised at 50°C the sample consisted of mainly spherical particles (Figure 4.5). When 
synthesised at 100°C the sample produced silver nanoparticles which were predominantly 
irregular in shape. The shape trend found within all three temperatures was consistent across 
all starch concentration variants. The success of spherical particle production using starch as 
the capping agent at synthesis temperature of 50°C has been demonstrated in other research 
(47). Furthermore, the production of irregular shaped particles at a synthesise temperature of 
100°C is likely due to the heat’s effect on the starch molecules’ ability to cap the nanoparticles 
correctly. Ghaseminezhad et al. (125) and Mohan et al. (47) used a synthesis temperature of 50°C 
and 40°C respectively and showed the production of well-formed spherical nanoparticles of 
a similar size.  
The production of cubic particles, using starch as the capping agent, (at a synthesis 
temperature of 20°C) is a novel finding which, to my knowledge, has not yet been reported. 
Unfortunately, however, the cubic sample produced using the chemical reduction synthesis, 
with starch as the capping agent, showed large nanoparticle size deviation and at best an 85% 
cubic particle majority (Figure 4.4). In future work this synthesis could be further refined in 
order to potentially produce a more uniform product, this could possibly be achieved by 
altering and refining the silver to starch ratio. The success of such an achievement would be 
profound as current methods of cubic nanoparticle synthesis involves long intensive synthesis 
using an extensively long list of chemical, equipment and precise environmental controls (87).  
For the chemical reduction using PVP as the capping agent all samples showed a majority of 
spherical particles and the percentage of cubic particles increased with rising temperature. 
The literature has suggested that when producing cubic nanoparticles with PVP as the capping 
agent high temperatures are required, however the quoted temperatures are much higher at 
140-150°C(84, 87). This suggests that if the temperatures were further increased then it may be 
possible to achieve even larger percentages of cubic particles 
The silver nanoparticle suspension was sensitive to PVP concentration changes, varying in 
shape between the 5 and 10mg/ml concentrations. Research by Wiley et al. (102) and Sun et 
al. (84) have highlighted the importance of using the correct concentration of PVP to produce 
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the desired outcome. It was found that sample shapes became slightly more irregular with 
increased PVP concentrations.  
The heat reduction synthesis performed at 150 and 170°C produced two distinct sets of 
particle shapes. For the synthesis performed at 150°C spherical shape particles were 
produced. When the synthesis temperature was increased to 170°C the silver nanoparticles 
produced were spherical and rod-like in shape. Higher synthesis temperatures were expected 
to produce some rod-shaped particles. This is due to the high energy created in the reaction 
allowing the formation of twin seeded particles (60, 102). Both Gorka et al. (119) and Wiley et al. 
(123) demonstrated similar results with elevated temperatures producing rod-shaped silver 
nanoparticles. Gorka et al. (119), interestingly produced rods with the addition of sodium 
chloride and iron nitrate.  
Based on the current literature the result of the heat reduction method at 150°C should have 
produced cubic shaped nanoparticles, however, not a single cube was identified during 
multiple synthesis attempts. Literature produced by Zhang et al. (91) and Ruditskiy et al. (11)  
showed this cubic shape when following this method of synthesis. Further, the protocol of 
Skrabalak et al. (87) which is almost identical to that which was used in this study still produced 
a differently shaped product. It is important however to consider the potential differences in 
the syntheses. An important consideration is the variance in temperature at which the 
reagents were synthesised and whether the EG had been allowed to absorb too much 
moisture. The method by Ruditskiy et al. (11) further indicated that the addiction of Br¯ ions, 
through the addition of sodium borohydride to the heat reduction synthesis, produced a 
greater percentage of cubic shapes. Wiley et al. (86), Zhang et al. (91) and Han et al. (92) also 
found that if HCl was added the cubes became less rounded and sharper. In future 
experimentation the addition of sodium borohydride to the already developed heat reduction 
method could produce a cubic shape. The heat reduction methods are extensive and involve 
strict control of all experimental parameters during the synthesis, making it difficult and 
expensive to easily replicate.  
 
The shape of the silver nanoparticles produced by these methods alter with a variation in 
temperature suggesting that temperature plays a key role in the synthesis of different particle 
shapes. However, the products of different temperatures were not the same across all 
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methods or capping agents. Synthesis via chemical reduction with starch as the capping agent 
showed a decrease in cubic shape percentage and an increase in irregular shape when 
temperature was increased. Alternately, chemical synthesis using PVP as the capping agent 
showed an increase in cubic shape percentage when temperatures were increased. Heat 
reduction synthesis however, showed an increased percentage in both rod, and irregularly 
shaped particles, when the temperature was increased.  
Silver nanoparticles can come in many different shapes. The synthesis methods used 
produced spherical, cubic, rod and irregularly shaped nanoparticles. Characterising 
nanoparticle shape is important in order to fully understand the properties of a silver 
nanoparticle. This is because different nanoparticle shapes have different surface properties 
(11, 60, 86, 101, 126). The majority of silver nanoparticle research has been conducted on spherical 
particles and the knowledge and understanding of the other shapes are quite limited in 
comparison. Recently, cubic silver nanoparticles have received particular attention due to 
their potential as a catalyst for epoxidation reactions and as substrates for plasmonic sensing 
but their position as an antimicrobial is not well known (11, 91).  
Not producing cubic silver nanoparticle in the heat reduction method was an unexpected 
result, however the identification of cubic nanoparticles in the chemical reduction method 
with starch is novel and worthy of reporting (Figure 4.3). Spherical silver nanoparticles have 
on many occasions been shown to possess antimicrobial properties. However, the 
antimicrobial properties of cubic and rod shape nanoparticles are not well known, and this 
study therefore provides a substantial contribution to the literature. 
The silver nanoparticle synthesis methods produced different silver nanoparticle products, 
and variation within methods was also identified. Selection of a single best method is not 
appropriate as the various methods have different attributes which make them a good 
candidate for future work and practical applications (Table 5.1). The heat reduction method 
with a synthesis temperature of 150°C produced the most uniform product with both a small 
standard deviation and average particles size. However, the silver nanoparticles produced by 
the heat reduction method used toxic chemicals which could be potentially harmful where 
the chemical reduction method does not use such harsh chemicals. However, the sample 
produced by the chemical method generated larger particles which have larger size 
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deviations. Thus, the most appropriate method choice depends predominantly on the 
intended use of the silver nanoparticles.   
 
5.3. The antimicrobial effect 
The uses of silver nanoparticles such as biosensors, substrates for SERS or as a catalyst are 
extensive but it is most important and most heavily discussed for its potential as an 
antimicrobial agent (91, 97). As presented earlier, silver nanoparticles are already commonly 
used as an antimicrobial in products such as textiles, cosmetics, detergents and many types 
of medical equipment where they have proven to be particularly useful as an antimicrobial 
capable of killing MR microbial strains (46, 97). However, little is known about whether different 
silver nanoparticle characteristics and synthesis methods produce a silver nanoparticle with 
a differential antimicrobial effect. 
Before the antimicrobial effect of the silver nanoparticles was tested the reagents used were 
tested to ensure they were not having any adverse effects on the microorganisms. In this 
project it was found that dissolved silver nitrate (silver ions) was not able to inhibit growth at 
the same silver concentrations as the silver nanoparticles. The silver nitrate or silver ion 
solution was not as effective an antimicrobial as silver nanoparticles. Mohan et al. (47) found 
a similar result producing a smaller inhibitory zone for silver nitrate than with the silver 
nanoparticles (16±8nm). Conversely Radzig et al. (24) found that silver ions inhibited bacterial 
growth at a lower concentration than silver nanoparticles (8.3±1.9nm), thus having a greater 
antimicrobial effect than silver nanoparticles. This highlights the inconsistency continuously 
noticed in silver nanoparticle research. The concentrations of PVP, starch, EG and Na₂S 
present in the synthetic methods were tested and shown to have no ability to inhibit bacterial 
growth (Section 4.5.1-2, Appendix 13). Thus, the antimicrobial effects presented in the 
following text and those in Section 4.5. can be attributed to the silver nanoparticles alone.  
It was found that the silver nanoparticles produced via the chemical reduction method with 
either starch or PVP as the capping agents produced a strong antimicrobial effect against P. 
aeruginosa and E. coli but had a limited effect against S. aureus with little to no effect against 
C. albicans (Table 5.2). The chemical reduction synthesis with the two capping agents, starch 
and PVP, showed the strongest antimicrobial effect within samples containing small (32-
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58nm) spherical silver nanoparticles. The silver nanoparticles produced via heat reduction 
however were effective against all 4 microorganisms. 
 
Table 5.2 Summary table of the best MIC and MBC results for the two synthesis methods (presented in Tables 
4.8-13). Data is an average of all duplicates for the specified synthesis condition. 
   Minimum Inhibitory Concentration (µg/ml) 
Method 
Capping 
agent 
Synthesis 
condition 
P. aeruginosa E. coli S. aureus C. albicans 
Chemical 
reduction 
Starch 20°C 3 6 >12 >12 
  
50°C, 
5mg/ml 
3 6 12 >12 
 PVP 20°C 3 6 6 >12 
Heat 
Reduction 
PVP 150°C 3 3 3 6 
  170°C 1.5 3 3 6 
   Minimum Bactericidal Concentration (µg/ml) 
Method 
Capping 
agent 
Synthesis 
condition 
P. aeruginosa E. coli S. aureus C. albicans 
Chemical 
reduction 
Starch 20°C 12 12 >12 >12 
  50°C 12 >12 >12 >12 
 PVP 20°C >12 >12 >12 >12 
Heat 
Reduction 
PVP 150°C 6 3 >12 12 
  170°C 3 3 >12 12 
 
When starch was used as the capping agent the silver nanoparticles were most effective at 
synthesis temperatures of 50°C producing an MIC of 3µg/ml against P. aeruginosa, 6µg/ml for 
E. coli, 12µg/ml for S. aureus and >12µg/ml for C. albicans (Table 5.2). Mohan et al. (47) 
synthesised starch capped silver nanoparticles (16±8nm) and reported an MIC of 10.7-21.4 
µg/ml for P. aeruginosa and E. coli. The results indicate that the nanoparticles in their study 
were slightly less effective than the 3µg/ml for P. aeruginosa and 6µg/ml for E. coli reported 
in this study. Research which used other plant biomass by Kora et al. (46), Das et al. (9) and 
Sharma et al. (106) also showed a similar microbial inhibition. In this study a similar 
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antimicrobial effect was observed at a synthesis temperature of 100°C and 20°C. The 
nanoparticles synthesised at 20°C were large (134nm) and the majority were cubic in shape, 
while those at 100°C were also large (244nm) but irregular in shape. The particles synthesised 
at 50°C were spherical in shape with large average particle sizes, when synthesised with 10 or 
50mg/ml of starch, whereas small sizes were observed when synthesised with 5mg/ml of 
starch. For the synthesis of starch capped silver nanoparticles, despite size and shape 
variations, the antimicrobial effect of the silver nanoparticles remained similar. 
For the synthesis using PVP as the capping agent the silver nanoparticles produced a greater 
antimicrobial effect when synthesised at 20 and 50°C and lesser at 100°C. At a synthesis 
temperature of 20°C the PVP capped silver nanoparticles produced an MIC of 3µg/ml for P. 
aeruginosa, 6µg/ml for E. coli and S. aureus and >12µg/ml for C. albicans (Table 5.2). The MIC 
results from the chemical synthesis of silver nanoparticles, using PVP as the capping agent, 
were consistent with that of the literature. The study of Kubo et al. (44) presented results with 
a slightly stronger antimicrobial effect using PVP capped silver nanoparticles with MIC results 
of 1µg/ml for E. coli and 3µg/ml for S. aureus compared to this study where 6µg/ml was 
effective. Bondarenko et al. (43) also gave a similar antimicrobial effect using PVP capped silver 
nanoparticles. For the synthesis with PVP, spherical shapes were the majority although at 
100°C the percentage of cubic and irregular particles increased. These results suggest that in 
the case of chemically reduced PVP capped silver nanoparticles the spherical nanoparticles 
may have a greater antimicrobial efficacy than the cubic or irregular shapes. Spherical silver 
nanoparticles are actually considered to be quasi sphere, this is because they are made up of 
a combination of {100} and {111} facets (57). Cubic particles are made up entirely of {100} 
facets while octahedrons and rods and triangular prisms are comprised mostly of {111}. It was 
found by Pal et al. (51) and Sadeghi et al. (62) that the {111} surface facet is more antimicrobial 
and more ion releasing than the {100} facet. As such the increased antimicrobial effect of the 
spherical particles over that of the cubic and irregular shapes could be due to this increase in 
the {111} facet found in spherical nanoparticles. 
The silver nanoparticles synthesised by the heat reduction method showed the strongest 
antimicrobial effect across all four microbes. The MICs for the two synthesis temperatures 
were very similar with only a slightly better antimicrobial effect on P. aeruginosa for the 
synthesis at 170°C (Table 5.2). At a synthesis temperature of 150°C the MICs were 3µg/ml for 
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P. aeruginosa, E. coli and S. aureus and 6µg/m for C. albicans. To my knowledge the MIC of 
silver nanoparticles produced by this method has not previously been determined. However, 
a paper by Sedira et al. (127) using a heat reduction method, did perform a disc diffusion test 
on bacteria in which inhibition was found up to 29mm for P. aeruginosa. Despite the heat 
reduction method being effective against all four microbes, the silver nanoparticles produced 
by this synthesis method were only slightly more effective against P. aeruginosa and E. coli 
than the chemical reduction methods. However, the silver nanoparticles produced via the 
heat reduction method were much more effective at inhibiting C. albicans, requiring 6µg/ml 
to inhibit growth. Whereas, in the chemical reduction methods concentrations greater than 
12µg/ml were required. S. aureus was also slightly more susceptible to the silver 
nanoparticles produced in the heat reduction method than those in the chemical reduction 
method requiring a silver nanoparticle concentration of 3µg/ml as opposed to 6-12µg/ml. This 
indicates that silver nanoparticles produced using the heat reduction method have a higher 
antimicrobial effect against a larger range of microorganisms. 
 
The ability of an antimicrobial to have an effect against a range of bacteria and bacterial types 
is an uncommon and promising result. Producing nanoparticles which present an 
antimicrobial effect to a wide range of microorganisms is ideal for the practical application of 
the silver nanoparticle(13). Panáček et al. (13) however, does warn about strain dependency, 
highlighting the antimicrobial properties observed are strain dependent and does not mean 
it is true for all strains of that microbial type. In future work the range of effectiveness 
demonstrated by the silver nanoparticles could be verified by test a broader spectrum of 
strains and species. The slight differences in the antimicrobial properties noticed amongst the 
microbes are also observed in commonly used antibiotics and as such are not concerning (128, 
129). The ability of silver nanoparticles to inhibit growth of a broad range of microbial type is a 
promising characteristic and demonstrates the potential for the silver nanoparticles, 
synthesised using the methods outlined, for practical applications. 
 
There has been a number of research papers exploring the effect of the size of silver 
nanoparticles and their antimicrobial properties. Ivask et al. (59) and Agnihotri et al. (48) both 
demonstrated an increased antimicrobial effect with smaller nanoparticle sizes with spherical 
Darcy Burns-Dunn, 18018282                                                                                               
86 
 
particles. However in this study, the synthesis of silver nanoparticles via chemical reduction 
using starch as the capping agent this was not the case. At a synthesis temperature of 50°C 
and a starch concentration of 5mg/ml the silver nanoparticles had an average particle size of 
32-33nm. Yet at starch concentration of 10mg/ml the average silver nanoparticles size was 
224 and 206nm. Despite this large size difference little change in antimicrobial properties was 
observed with all treatments showing an MIC of 3µg/ml. Similarly, the heat reduction method 
suspension showed a much smaller average particles size at a synthesis temperature of 150°C 
however, the antimicrobial properties of both synthesis temperatures (150 and 170°C) were 
similar. Size difference in the chemical reduction synthesis with PVP as the capping agent 
were minimal and no assumptions on the effect of size could be determined. The silver 
nanoparticles used by Ivask et al. (59) and Agnihotri et al. (48) were citrate capped whereas the 
silver nanoparticles used in this study were capped using PVP or starch. In a different study 
by Ivask et al. (93) it was demonstrated the differences in antimicrobial properties for silver 
nanoparticles using different capping agents. It is possible that the altered composition of the 
silver nanoparticles resulted in a different antimicrobial property in relation to particle size. 
The ability of the silver nanoparticles produced by the two reduction methods to kill the 
microorganisms was also tested. The bactericidal and fungicidal properties of silver 
nanoparticles are not always reported however, this property is quite important and provides 
a multitude of benefits and a wider range of applications for silver nanoparticles. Not only can 
they be used for preventing microbial growth but also effectively killing the microbes allowing 
silver nanoparticles to eliminate infection(9). For the silver nanoparticles synthesised using the 
chemical reduction method, limited bactericidal properties were observed at the tested 
concentrations. Mohan et al. (47) demonstrated an MBC of 21.4µg/ml against P. aeruginosa 
and E. coli for silver nanoparticles capped with starch. The starch capped silver nanoparticles 
in this study showed an MBC at 12 µg/ml against P. aeruginosa and E. coli. A strong killing 
property was identified in the silver nanoparticles synthesised using the heat reduction 
method where both synthesis temperatures produced a similar result. The silver 
nanoparticles synthesised by heat reduction showed a strong bactericidal effect against P. 
aeruginosa and E. coli producing MBCs of 3 and 6µg/ml. The bacteria S. aureus however, was 
not killed by the silver nanoparticles. These silver nanoparticles also showed a limited 
fungicidal affect against C. albicans. The bactericidal and fungicidal properties of the silver 
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nanoparticles produced by the heat reduction method have not previously been 
demonstrated.  
In summary, bactericidal and fungicidal properties were demonstrated by the silver 
nanoparticle produced by both synthetic methods. Chemical reduction methods at low 
synthesis temperatures of 20 and 50°C and heat reduction synthesise at temperatures of 150 
and 170°C produced the greatest antimicrobial effects, indicating heat reduction methods 
provided the most effective antimicrobial and disinfectant properties against the four tested 
organisms used in this study. 
 
5.4. The effect of silver nanoparticle aging 
Not only is it important for the silver nanoparticles to produce an antimicrobial effect but it is 
also important to understand the aging of the particles produced, such that it can perform its 
antimicrobial purpose without progressing into water ways and affecting the environment. 
The application of silver nanoparticles as an antimicrobial in textile, cosmetics, detergents 
and medical equipment has resulted in the leakage of silver nanoparticles into the 
environment (34, 130). Unfortunately, little is known about the effect silver nanoparticles have 
on the environment, particularly on susceptible aquatic ecosystems. In vivo tests with silver 
nanoparticles, particularly those less than 10nm in size have been shown to effect early life 
stage development, such as spinal cord deformities and cardiac arrhythmia, often causing 
death in fish (113, 131). Silver nanoparticles have also been shown to accumulate in the gills and 
liver tissue of fish (132, 133). Even less is known about what happens to the silver nanoparticles 
over time when left to age in the environment. Understanding the aging of silver 
nanoparticles is crucial in producing and managing silver nanoparticles to limit environmental 
impact. The chemical reduction method with starch and PVP as the capping agent as well as 
the heat reduction method were all aged for a week at room temperature in the laboratory 
to better understand this effect. The characteristics and antimicrobial effect of the aged 
particles was determined. 
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5.4.1. Characterisation of chemically reduced starch capped silver nanoparticles after 7-days  
For the silver nanoparticles produced by chemical reduction with starch as the capping agent, 
after a 7-day aging period the silver nanoparticles were found to have changed in size and 
shape. The aged particles synthesised at 20°C developed rounded shapes losing their cubic 
shape and becoming majority spherical. Those synthesised with low starch concentrations of 
5 and 10mg/ml showed a reduction in irregularly shaped particles and an increase in spherical 
shaped particles. These particles also became smaller, most reducing in size by 100nm to an 
average of 91.2nm. The shrinking in nanoparticle size is possibly due to the silver 
nanoparticles dissolution over time. Silver ion release in silver nanoparticles has been 
identified and demonstrated to provide an additional antimicrobial effect(51, 134). As the 
nanoparticles continue to release silver ions it would then be expected that the silver 
nanoparticles would eventually become inert. Unfortunately however, many reports such as 
that by Bar‐Ilan et al. (135) and Scown et al. (132) showed an increase in toxicity to aquatic 
animals with a reduced silver nanoparticle size, although it is worth noting that this toxicity 
was also observed with fresh nanoparticles which were less than 10nm in diameter. The 
smallest particles size observed in this study for the starch capped silver nanoparticles was 
19nm with the average result being at 91nm. If the shrinkage did continue the nanoparticles 
would be at risk of causing some toxicity to aquatic animals. However, if the particles are 
becoming inert it is possible that they would soon not be toxic in nature. In future work it 
would be crucial to identify whether these silver nanoparticles which have been labelled as 
safe and environmentally friendly are what they claim.   
The silver nanoparticles produced by chemical reduction with starch as the capping agent 
showed a variation in antimicrobial effectiveness after the nanoparticles were aged for a 
week. C. albicans remained unaffected by the silver nanoparticles (Table 4.14) and E. coli 
become unaffected by the silver nanoparticles after the 7-days of aging. P. aeruginosa and S. 
aureus retained some susceptibility to the silver nanoparticle samples (Table 5.3). This loss of 
antimicrobial effect is not a negative attribute as might be assumed. For an environmentally 
friendly silver nanoparticle sample this loss in antimicrobial effect means that these 
nanoparticles are less likely to progress into natural ecosystems and disrupt healthy microbial 
growth in the environment (136, 137). Stability of the silver nanoparticles tested in this research 
project does not correlate to shelf-life nor has the shelf-life been tested. The samples in these 
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tests were exposed to room temperature and artificial light. Optimal storage for silver 
nanoparticles however is in refrigeration without any light exposure (138). The purpose of the 
aging was to begin to understand how the nanoparticles would age once in use or in the 
environment. The silver nanoparticles produced by chemical reduction with starch as the 
capping agent showed a reduced antimicrobial effect after a week of aging compared to the 
fresh sample. P. aeruginosa was the only microorganism which showed strong susceptibility 
to the aged silver nanoparticles.  
The loss in antimicrobial effect in starch capped silver nanoparticles is likely correlated to the 
loss of silver ions from the nanoparticle over the 7-day period. The release of silver ions has 
been identified as one of the ways silver nanoparticles have an antimicrobial effect, however, 
this ion release is finite (134, 139, 140). As the silver nanoparticles lose their silver ions, they are 
becoming more inert and losing their antimicrobial effect.  However, P. aeruginosa was 
equally affected by both the fresh and week aged starch capped silver nanoparticle samples. 
It is possible that in the case of P. aeruginosa it is not only susceptible to the silver ions but 
also to the silver nanoparticles themselves. It has been suggested that the antimicrobial effect 
might also be caused by the direct interaction of the silver nanoparticles within the cell 
membrane and the uptake of silver nanoparticles by the cell (26, 27, 141) . However, it has been 
suggested that both may be true, that silver ion release and direct silver nanoparticle to cell 
interaction caused the damaging effect to microbes (29). As such, different microorganisms 
may be susceptible to different aspects of silver nanoparticles antimicrobial properties. In 
future work it would be important to experimentally determine the antimicrobial effect and 
why it is reduced in aged particles. 
In summary, the silver nanoparticles that were synthesised by chemical reduction with starch 
as the capping agent and aged for 1 week became small and spherical. These silver 
nanoparticles also lost most of their antimicrobial effectiveness after a 7-day aging period. 
Further, starch is an organic compound which is safe for both humans and the 
environment(105). With further research it could become an environmentally friendly 
alternative method for the production of bulk, short lived silver nanoparticles.  
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5.4.2. Characteristics of chemically reduced PVP capped silver nanoparticles after 7-days 
The silver nanoparticles produced using the chemical reduction method with PVP as the 
capping agents showed the most dramatic change in nanoparticle characteristics. The sample, 
originally made up of spheres, became mostly large rod-shaped particles after the 7-day aging 
period. The silver nanoparticles sample showed no cubic shaped particles and very few 
spherical shapes after the 7-day aging. Most synthesis conditions showed a majority 
distribution of rods, ranging from 280 to as large as 2400nm in length. Tejamaya et al. (142) 
described PVP as being strongly bound to the core, though potentially permeable to solutes 
and solvents. It is possible that the water is permeating the capping agent and disrupting the 
silver nanoparticles causing the silver nanoparticles to agglomerate into these larger rod-
shaped particles, however further research is needed. 
Silver nanoparticles synthesised using the chemical reduction method with PVP as the capping 
agent and aged for one week gave an inhibitory effect different to that of the fresh sample. 
P. aeruginosa was the most susceptible to the silver nanoparticles with both the day zero and 
day seven MIC’s remaining at 3µg/ml (Table 5.2 and 5.3). The silver nanoparticles produced 
using chemical reduction, using PVP as the capping agent, after a one-week aging period 
showed  limited antimicrobial effects against E. coli or C. albicans. The E. coli treated with the 
fresh silver nanoparticles gave an inhibitory concentration range of 3-6µg/ml while after 7-
days of aging the necessary inhibitory concentration became >12µg/ml. For the chemical 
reduction with PVP as the capping agent a loss in antimicrobial effectiveness after a week was 
clearly identified. 
The silver nanoparticles produced by chemical reduction with PVP as the capping agent 
showed a reduction in antimicrobial effect, except in P. aeruginosa. This antimicrobial activity 
loss is possibly the result of the silver ion loss, however further research is required to 
determine if this is the case. This could be conducted by determining the silver nanoparticle 
charge before and after the aging period. If the nanoparticle charge has neutralized it could 
be assumed that the positively charged silver ions have been released(5).  
In both the chemical reduction methods, the cubic shapes which were present in the fresh 
sample were no longer noticed in the aged samples. Cubic nanoparticles are completely made 
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up of {100} facets(84). This surface facet configuration is known to be unstable(61) thus these 
cubic nanoparticles may be breaking down, or rounding, due to their instability. 
 
Table 5.3 Summary table of the best MIC results for the two synthesis methods, aged for 7-days (Table 4.14-
16). Data is an average of all duplicates in the specified synthesis conditions. 
   Minimum Inhibitory Concentration (µg/ml) 
Method 
Capping 
agent 
Synthesis 
condition 
P. aeruginosa E. coli S. aureus C. albicans 
Chemical 
reduction 
Starch 20°C 3 >12 12 >12 
 PVP 
20°C, 
5mg/ml 
3 >12 12 >12 
Heat 
Reduction 
PVP 150°C 3 3 12 12 
  170°C 3 3 12 12 
 
 
5.4.3. Characteristics of heat reduced silver nanoparticles after 7-days 
For the synthesis of silver nanoparticles by heat reduction, for both synthesis temperatures 
of 150 and 170°C, an increase in average particle sizes was observed after a week of aging. At 
a synthesis temperature of 150°C an increase in the percentage of irregular shapes was also 
identified (Figure 4.32). For the synthesis temperature of 170°C there was a reduction in rod 
percentages and an increase in irregularly shaped particles. Izak-Nau et al. (138) found that 
factors such as exposure to light cause the aging silver nanoparticles to aggregate and form 
larger and more irregular shapes, affirming the finding, but only at the higher 170°C 
temperature was there a proportion of rod particles in the aged sample.  
In terms of antimicrobial activity, the silver nanoparticles produced using the heat reduction 
method after being aged for a week showed a varied result when compared to that of the 
fresh samples. For P. aeruginosa and E. coli the particles produced at 150°C and 170°C 
remained just as susceptible to silver nanoparticles after 1 week of aging (Table 5.3). For S. 
aureus and C. albicans both the synthesis temperatures of 150°C and 170°C resulted in a small 
loss in antimicrobial effectiveness of the silver nanoparticles. The varied microbial effects of 
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aged heat reduction synthesised silver nanoparticles has not, to my knowledge, previously 
been tested. 
For the silver nanoparticles produced by the heat reduction method, harsh solvents and 
reagents are required in its synthesis making it a less environmentally friendly option(34). 
However, the 150°C heat reduction synthesis of silver nanoparticles produced a highly 
uniform product. Further, these silver nanoparticles showed a bactericidal and fungicidal 
effect while fresh, and they were able to retain a strong though diverse antimicrobial effect 
after a week of ageing. The strong, bactericidal and fungicidal effects produced by the heat 
reduced silver nanoparticles means that these silver nanoparticles could be useful for dealing 
with bacterial infection and preventing their growth. Further testing is needed, but such silver 
nanoparticles might have applications in hospital environments for dealing with MR 
microorganisms and preventing their growth and devastating health effects. 
The silver nanoparticles synthesised by heat reduction show a longevity not found using the 
chemical reduction approach. The heat reduction silver nanoparticles were able to maintain 
their antimicrobials effect after the 7-day aging, remaining most effective against the Gram-
negative bacteria. While this longevity might be useful for applications like medical 
equipment, it could however result in prolonged harmful effects if it is able to leak into 
ecosystems(114). The strong antimicrobial effect of the heat reduced silver nanoparticles could 
persist and have negative effects on natural non-target microbiomes. Further, the small size 
of the day zero nanoparticles means that it would likely have a negative effect on fish species 
if released into the environment (113). After the week of aging however, the heat reduced silver 
nanoparticles were no longer less than 10nm, reducing the damaging effects to fish. With 
strict controls and policies on the use and disposal of these silver nanoparticles they could, 
however, become a valued asset in the fight against MR microorganisms. 
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5.5. Summary 
The synthetic approaches explored in this work provide silver nanoparticles of different 
morphologies and longevities. Various methods have different attributes which make them a 
good candidate for future work and give different practical applications. Thus, the most 
appropriate method of choice depends predominantly on the intended use of the silver 
nanoparticles. Furthermore, these decisions should include an evaluate of the potential 
environmental consequence. 
The products of the chemical reduction synthesis methods produced silver nanoparticles with 
a lower environmental impact, as a result of a short-lived antimicrobial effect. The two 
capping agents tested with this method were starch and PVP. When the silver nanoparticles 
were capped with starch, they produced cubic and spherical particles. When PVP was used as 
the capping agent the product was predominantly spheres. The chemical reduced silver 
nanoparticles produced strong antimicrobial effects against the Gram-negative bacteria but 
were less effective against the Gram-positive bacteria and fungus. However, after a week of 
aging the silver nanoparticles los their amicrobial effect, except against P. aeruginosa. The 
starch capped silver nanoparticles when aged, reduced in size and would likely continue to do 
so until completely broken down. The PVP capped silver nanoparticles became large and rod 
shaped and with continued aging the PVP capped nanoparticles would likely become larger 
still and begin to drop out of solution.  
The heat reduction synthesis produced uniform silver nanoparticles with a highly effective 
antimicrobial property. Furthermore, these samples inhibited the growth of a range of 
microorganisms and were able to retain an antimicrobial effect for a week in ambient 
conditions (Section 3.1.3.). The Gram-positive bacteria and fungus were slightly less 
susceptible to silver nanoparticles after a week while the Gram-negatives were equally 
affected in both fresh and aged samples. The heat reduction synthesis (150°C) produced small 
spherical particles which become slightly larger after the week of aging. The strong 
disinfectant properties of the heat reduced silver nanoparticles against a range of types of 
microorganisms make them a candidate for dealing with MR strains of bacteria in hospital, 
however further study is needed into their full microbial spectrum of effect. 
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By understanding the characteristic and the aging process and mechanisms of silver 
nanoparticles we can begin to select synthetic methods that are fit for purpose. For instance, 
if selecting a method for short lived silver nanoparticles where it is important that the sample 
become ineffective quickly in order to reduce environmental impact. Or, for longevity, silver 
nanoparticles which need to retain a strong antimicrobial effect for long periods of time. By 
understanding the aging process of synthesised silver nanoparticles, we can begin to make 
educated decisions on the type of silver nanoparticle synthesis methodologies that ought to 
be used. 
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Chapter 6. Conclusions and future work 
6.1. Conclusions  
The aims of this study were to investigate and compare synthetic methods, appraise their 
antimicrobial properties and determine the effect of silver nanoparticle aging. It was 
speculated in this research that the method of silver nanoparticle synthesis affects the size 
and shape of the silver nanoparticles but also its antimicrobial properties of fresh and aged 
particles.  
This research is, as far as I am aware, the first of its kind to experimentally determine the 
antimicrobial properties of silver nanoparticles synthesised via a heat reduced method (or 
polyol method). The heat reduction synthesis method produced the smallest and most 
uniform nanoparticle products. It also produced the greatest antimicrobial effect against two 
Gram-negative bacteria, a Gram-positive bacterium and a fungus. Further particles 
synthesised by this method retained their antimicrobial effect after aging for one week, 
making them a promising candidate for practical applications such as in hospitals for treating 
MR microorganisms. However, its longevity has associated environmental effects if allowed 
to progress into the natural environment (34, 113). Tight controls would be required around 
production and use of such silver nanoparticles to prevent the leakage of nanoparticles with 
this level of stability.  
Chemical reduction synthesis has been highlighted as an alternative method choice. This 
method is a more environmentally friendly option in both its synthesis and shorter-lived 
antimicrobial effect. Furthermore, the nanoparticles altered dramatically after the week of 
aging, breaking down in the case of starch and aggregating to large particles in the case of 
PVP. However, the antimicrobial effect presented by the chemically reduced silver 
nanoparticles only had an antimicrobial effect against the bacteria, with a strong effect 
against the Gram-negative bacteria, but no inhibition in fungal growth was observed.  
The methods of synthesis and selection of capping agent have, in this study, been identified 
as playing a key role in nanoparticle size, shape, antimicrobial properties and the aging 
process. This research provides the first step in a deeper understanding of the importance of 
synthesis choice when producing silver nanoparticles. This study is the first of its kind to 
highlight the effect of synthesis methods in both the long-term and short-term on the 
Darcy Burns-Dunn, 18018282                                                                                               
96 
 
nanoparticle morphology, antimicrobial properties and its potential persistence in the 
environment.  
For the production of highly antibacterial and antifungal silver nanoparticles, the heat 
reduction syntheses were found to be the best option, however, care must be taken to 
prevent their release into the environment. Alternatively, for the production of silver 
nanoparticles with antimicrobial properties, but a lower environmental impact, the chemical 
reduction method is the best option. Understanding the properties of silver nanoparticles in 
both the short-term and long-term is vital for producing the most effective antimicrobials 
with the lowest environmental impact. 
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6.2. Future work 
The aims and research question in this study were limited by the time frame of the project. If 
time had been available a number of further experiments could have further supported the 
data. A better understanding could have been achieved by determining the effect of 
nanoparticle shapes on its characteristics, by testing nanoparticles of the same size and 
different shapes. If time had allowed, more antimicrobial testing could have been performed 
to better understand the inhibitory role, including testing more species and strains, and 
testing particles aged over a longer time frame. In future work, testing of the mechanism on 
the antimicrobial effect would also be crucial, with a focus on the correlation between silver 
ion release and the loss of antimicrobial effect over time. It would also be vital to determine 
if inert silver nanoparticles have the same toxic effect on aquatic environments as reported 
with fresh silver samples. 
By developing the synthesis to produce a greater uniformity of shape and size, in the starch 
capped and chemical reduction silver nanoparticles, more assumptions could have been 
made about the effect of shape and size on the antimicrobial properties and the aging effect 
of the silver nanoparticles. The antimicrobial properties of cubic and rod shape nanoparticles 
are less well known. Furthermore, if this cubic synthesis using the starch capped silver 
nanoparticles, was further refined it could be identified as a novel approach for production of 
cubic silver nanoparticles. Refining the syntheses to produce more uniform shapes would 
have allowed for more reliable conclusions on the effect of shape and size on the nanoparticle 
properties. 
If time had allowed, it would have been important to test aged silver nanoparticles at higher 
concentrations and determine MBC/MFCs. This would have allowed the identification of an 
exact inhibitory concentration value (MIC). Furthermore, it would be interesting to determine 
whether the chemically reduced nanoparticles could inhibit fungal growth of C. albicans at 
the higher silver nanoparticle concentrations.  
In future work it would also be important to extend the ageing test, particularly in the case of 
particles produced by the heat reduction method, which were still effective after one week. 
This would provide an insight into how to manage heat reduced silver nanoparticles after 
their use, specifically how long they need to be contained. It would be fascinating to 
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determine whether the silver nanoparticles would continue to age, in respect to morphology, 
in the same way. For example, do the PVP capped chemically reduced nanoparticles continue 
to get larger and do the starch capped continue to get smaller? It would also be interesting 
to determine if the aging effect was the same when stored in the absence of light at 4°C, 
conditions under which a slower aging process would be expected.  
It would be interesting to experimentally determine whether the release of silver ions was 
the cause of the loss in antimicrobial effect. Silver ion release has been identified as one of 
the ways silver nanoparticles have an antimicrobial effect (134, 139, 140). As the silver 
nanoparticles lose their silver ions, it is expected that they are becoming less active and their 
antimicrobial effect would be lost. This could be determined by measuring the silver 
nanoparticle charge before and after the aging period. If the nanoparticle charge has become 
more neutral it could be determined whether the release of positively charged silver ions is 
related to their loss of antimicrobial activity (5). 
Reports by Bar‐Ilan et al. (135) and Scown et al. (132) showed an increase in toxicity to aquatic 
animals with a silver nanoparticle size of less than 10nm. However, the silver nanoparticles in 
these in vivo studies were fresh charged particles(132, 135). It would be important to determine 
if the aged inert silver nanoparticles were also less toxic to aquatic environments. This work 
is crucial to better understand the impacts of silver nanoparticles on the environment. 
In future research, the investigation of all these avenues of silver nanoparticle synthesis, 
characteristics, aging and environmental effect would enable production of silver 
nanoparticles with well understood short- and long-term effects. By understanding the effect 
of synthesis methods and the difference between nanoparticles produced through the 
various methods it will be possible to produce nanoparticles based on purpose, persistence 
and environmental impact.  
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Chapter 8. Appendix 
Appendix 1. UV-Vis results from all duplicates for the synthesis of silver nanoparticles by 
chemical reduction with starch as the capping agent. 
 
Appendix 2. SEM images of silver nanoparticles synthesised using chemical reduction with 
starch as the capping agent at varying temperatures and starch concentrations.  
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Appenix 3. UV-Vis results from all duplicates for the synthesis of silver nanoparticles by 
chemical reduction with PVP as the capping agent. 
 
Appendix 4. SEM images of silver nanoparticles synthesised using chemical reduction with 
PVP as the capping agent at varying temperatures and PVP concentrations.   
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Appendix 5. UV-Vis results from all duplicates for the synthesis of silver nanoparticles by 
heat reduction at 150 or 170°C. 
 
 
Appendix 6. SEM images of silver nanoparticles synthesised using heat reduction at 150 or 
170°C. 
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Appendix 7. UV-Vis results from all duplicates for the synthesis of silver nanoparticles by 
chemical reduction with starch as the capping agent after a 7-day aging period. 
 
Appendix 8. SEM images of silver nanoparticles synthesised using chemical reduction with 
starch as the capping agent at varying temperatures and starch concentrations after a 7-day 
aging period. 
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Appendix 9. UV-Vis results from all duplicates for the synthesis of silver nanoparticles by 
chemical reduction with PVP as the capping agent after a 7-day aging period. 
 
Appendix 10. SEM images of silver nanoparticles synthesised using chemical reduction with 
PVP as the capping agent at varying temperatures and PVP concentrations after a 7-day 
aging period.   
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Appendix 11. UV-Vis results from all duplicates for the synthesis of silver nanoparticles by 
heat reduction (150 or 170°C) after a 7-day aging period. 
 
 
Appendix 12. SEM images of silver nanoparticles synthesised using heat reduction at 150 or 
170°C after a 7-day aging period. 
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Appendix 13. MICs for the reagents used for the synthesis of silver nanoparticles. 
Reagent Minimum Inhibitory Concentration  
P. aeruginosa E. coli S. aureus C. albicans 
Na₂S >50µg/ml >50µg/ml >50µg/ml >50µg/ml 
EG >50% >50% >50% >50% 
PVP >14mg/ml >14mg/ml >14mg/ml >14mg/ml 
Starch >50mg/ml >50mg/ml >50mg/ml >50mg/ml 
Sodium 
borohydride 
>4.5mg/ml >4.5mg/ml >4.5mg/ml >4.5mg/ml 
AgNO₃ (Ag⁺) 
>12, 
>12µg/ml 
>12, 
>12µg/ml 
>12, 
>12µg/ml 
>12, 
>12µg/ml 
 
 
